FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Ford, K
   Latic, N
   Slavic, S
   Zeitz, U
   Dolezal, M
   Andrukhov, O
   Erben, RG
   Andrukhova, O
AF Ford, Kristopher
   Latic, Nejla
   Slavic, Svetlana
   Zeitz, Ute
   Dolezal, Marlies
   Andrukhov, Oleh
   Erben, Reinhold G.
   Andrukhova, Olena
TI Lack of vitamin D signalling per se does not aggravate cardiac
   functional impairment induced by myocardial infarction in mice
SO PLOS ONE
LA English
DT Article
ID LEFT-VENTRICULAR HYPERTROPHY; PARATHYROID-HORMONE LEVELS; D-RECEPTOR;
   PRIMARY HYPERPARATHYROIDISM; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; D
   SUPPLEMENTATION; D DEFICIENCY; ARTERIAL STIFFNESS; CONTROLLED-TRIAL
AB Epidemiological studies have linked vitamin D deficiency to an increased incidence of myocardial infarction and support a role for vitamin D signalling in the pathophysiology of myocardial infarction. Vitamin D deficiency results in the development of secondary hyperparathyroidism, however, the role of secondary hyperparathyroidism in the pathophysiology of myocardial infarction is not known. Here, we aimed to explore further the secondary hyperparathyroidism independent role of vitamin D signalling in the pathophysiology of myocardial infarction by inducing experimental myocardial infarction in 3-month-old, male, wild-type mice and in mice lacking a functioning vitamin D receptor. In order to prevent secondary hyperparathyroidism in vitamin D receptor mutant mice, all mice were maintained on a rescue diet enriched with calcium, phosphorus, and lactose. Surprisingly, survival rate, cardiac function as measured by echocardiography and intra-cardiac catheterisation and cardiomyocyte size were indistinguishable between normocalcaemic vitamin D receptor mutant mice and wild-type controls, 2 and 8 weeks post-myocardial infarction. In addition, the myocardial infarction-induced inflammatory response was similar in vitamin D receptor mutants and wild-type mice, as evidenced by a comparable upregulation in cardiac interleukin-1-beta and tumor-necrosis-factor-alpha mRNA abundance and similar elevations in circulating interleukin-1-beta and tumor-necrosis-factor-alpha. Our data suggest that the lack of vitamin D signalling in normocalcaemic vitamin D receptor mutants has no major detrimental effect on cardiac function and outcome post-myocardial infarction. Our study may have important clinical implications because it suggests that the secondary hyperparathyroidism induced by vitamin D deficiency, rather than the lack of vitamin D signalling per se, may negatively impact cardiac function post-myocardial infarction.
C1 [Ford, Kristopher; Latic, Nejla; Slavic, Svetlana; Zeitz, Ute; Dolezal, Marlies; Erben, Reinhold G.; Andrukhova, Olena] Univ Vet Med Vienna, Dept Biomed Sci, Vienna, Austria.
   [Andrukhov, Oleh] Med Univ Vienna, Sch Dent, Div Conservat Dent & Periodontol, Vienna, Austria.
RP Erben, RG (reprint author), Univ Vet Med Vienna, Dept Biomed Sci, Vienna, Austria.
EM Reinhold.Erben@vetmeduni.ac.at
FU Austrian Science Fund [FWF P 26534-B13]
FX This work was supported by a grant from the Austrian Science Fund (FWF P
   26534-B13) to Olena Andrukhova.
CR Adams JS, 2012, ARCH BIOCHEM BIOPHYS, V523, P95, DOI 10.1016/j.abb.2012.02.016
   Almqvist EG, 2002, SURGERY, V132, P1126, DOI 10.1067/msy.2002.128692
   AMANN K, 1994, J AM SOC NEPHROL, V4, P1814
   AMANN K, 1995, NEPHROL DIAL TRANSPL, V10, P2043
   Andrukhova O, 2014, MOL ENDOCRINOL, V28, P53, DOI 10.1210/me.2013-1252
   [Anonymous], 2017, R LANG ENV STAT COMP
   Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730
   Avenell A, 2012, J CLIN ENDOCR METAB, V97, P614, DOI 10.1210/jc.2011-1309
   Azizieh F, 2016, J INFLAMM RES, V9, P51, DOI 10.2147/JIR.S103298
   Bae S, 2013, J APPL PHYSIOL, V114, P979, DOI 10.1152/japplphysiol.01506.2012
   Bikdeli B, 2012, CIRC-CARDIOVASC QUAL, V5, P580, DOI 10.1161/CIRCOUTCOMES.111.964072
   Bikle DD, 2014, CHEM BIOL, V21, P319, DOI 10.1016/j.chembiol.2013.12.016
   BOGIN E, 1981, J CLIN INVEST, V67, P1215, DOI 10.1172/JCI110137
   BOGIN E, 1982, MINER ELECTROL METAB, V7, P151
   Bouillon Roger, 2014, Bonekey Rep, V3, P480, DOI 10.1038/bonekey.2013.214
   Calton EK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141770
   Cannell JJ, 2014, DERM-ENDOCRINOL, V6, DOI 10.4161/19381980.2014.983401
   Carroll WW, 2016, INT FORUM ALLERGY RH, V6, P605, DOI 10.1002/alr.21704
   Chen S, 2008, HYPERTENSION, V52, P1106, DOI 10.1161/HYPERTENSIONAHA.108.119602
   Chen SC, 2011, CIRCULATION, V124, P1838, DOI 10.1161/CIRCULATIONAHA.111.032680
   CRAN, 2015, VIS PAIR COMP
   CRAN, 2017, LEAST SQUAR MEANS VE
   Dadabhai AS, 2017, WORLD J HEPATOL, V9, P278, DOI 10.4254/wjh.v9.i5.278
   DOMINICZAK AF, 1990, CLIN SCI, V78, P127, DOI 10.1042/cs0780127
   Erben RG, 2002, MOL ENDOCRINOL, V16, P1524, DOI 10.1210/me.16.7.1524
   Fraser WD, 2009, LANCET, V374, P145, DOI 10.1016/S0140-6736(09)60507-9
   Gardner DG, 2013, AM J PHYSIOL-REG I, V305, pR969, DOI 10.1152/ajpregu.00322.2013
   GUILLEN I, 1995, AM J PHYSIOL-REG I, V269, pR229
   Gunta SS, 2013, NAT REV NEPHROL, V9, P337, DOI 10.1038/nrneph.2013.74
   Gurantz D, 2005, J MOL CELL CARDIOL, V38, P505, DOI 10.1016/j.yjmcc.2004.12.015
   Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491
   Kamycheva E, 2004, EUR J CARDIOV PREV R, V11, P69, DOI 10.1097/01.hjr.0000114706.27531.01
   Kendrick J, 2011, ADV CHRONIC KIDNEY D, V18, P113, DOI 10.1053/j.ackd.2010.12.003
   Khalili H, 2012, CLIN RES CARDIOL, V101, P321, DOI 10.1007/s00392-011-0394-0
   LAFFERTY FW, 1981, ARCH INTERN MED, V141, P1761, DOI 10.1001/archinte.141.13.1761
   Lee JH, 2011, AM J CARDIOL, V107, P1636, DOI 10.1016/j.amjcard.2011.01.048
   LEMIRE JM, 1995, J STEROID BIOCHEM, V53, P599, DOI 10.1016/0960-0760(95)00106-A
   Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391
   Manousaki D, 2016, CIRC-CARDIOVASC GENE, V9, P349, DOI 10.1161/CIRCGENETICS.116.001396
   MCCARTHY DM, 1984, LANCET, V1, P78
   Meems LMG, 2012, J STEROID BIOCHEM, V132, P282, DOI 10.1016/j.jsbmb.2012.06.004
   Milazzo V, 2017, WORLD J CARDIOL, V9, P14, DOI 10.4330/wjc.v9.i1.14
   Nappi S, 2000, CARDIOLOGY, V93, P229, DOI 10.1159/000007031
   Ni W, 2014, HYPERTENSION, V64, DOI 10.1161/HYPERTENSIONAHA.114.03971
   Nuzzo V, 2002, EUR J ENDOCRINOL, V147, P453, DOI 10.1530/eje.0.1470453
   Oliveira Gustavo B F, 2015, Front Cardiovasc Med, V2, P32, DOI 10.3389/fcvm.2015.00032
   Park CW, 1999, AM J KIDNEY DIS, V33, P73, DOI 10.1016/S0272-6386(99)70260-X
   Piovesan A, 1999, CLIN ENDOCRINOL, V50, P321, DOI 10.1046/j.1365-2265.1999.00651.x
   Saleh FN, 2003, EUR HEART J, V24, P2054, DOI 10.1016/j.ehj.2003.09.010
   Sandmann S, 2006, BLOOD PRESSURE, V15, P116, DOI 10.1080/08037050600586593
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Schocken DD, 2008, CIRCULATION, V117, P2544, DOI 10.1161/CIRCULATIONAHA.107.188965
   Simpson RU, 2007, J STEROID BIOCHEM, V103, P521, DOI 10.1016/j.jsbmb.2006.12.098
   Simpson RU, 2011, CIRCULATION, V124, P1808, DOI 10.1161/CIRCULATIONAHA.111.061234
   Snijder MB, 2007, J INTERN MED, V261, P558, DOI 10.1111/j.1365-2796.2007.01778.x
   STEFENELLI T, 1990, AM HEART J, V120, P590, DOI 10.1016/0002-8703(90)90016-Q
   Stefenelli T, 1997, J CLIN ENDOCR METAB, V82, P106, DOI 10.1210/jc.82.1.106
   Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007
   Tishkoff DX, 2008, ENDOCRINOLOGY, V149, P558, DOI 10.1210/en.2007-0805
   Turner NA, 2007, CARDIOVASC RES, V76, P81, DOI 10.1016/j.cardiores.2007.06.003
   Turner NA, 2009, AM J PHYSIOL-HEART C, V297, pH1117, DOI 10.1152/ajpheart.00372.2009
   VAITKEVICIUS PV, 1993, CIRCULATION, V88, P1456, DOI 10.1161/01.CIR.88.4.1456
   van Ballegooijen AJ, 2013, AM HEART J, V165, P655, DOI 10.1016/j.ahj.2013.02.014
   Wang L, 2010, ANN INTERN MED, V152, P315, DOI 10.7326/0003-4819-152-5-201003020-00010
   Willett AM, 2005, P NUTR SOC, V64, P193, DOI 10.1079/PNS2005420
   Witham MD, 2013, INT J CARDIOL, V167, P745, DOI 10.1016/j.ijcard.2012.03.054
   YANG SL, 1993, ARCH BIOCHEM BIOPHYS, V303, P98, DOI 10.1006/abbi.1993.1260
   Yin K, 2014, J INFLAMM RES, V7, P69, DOI 10.2147/JIR.S63898
NR 68
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 1
PY 2018
VL 13
IS 10
AR e0204803
DI 10.1371/journal.pone.0204803
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GV5EV
UT WOS:000446124700036
PM 30273386
OA DOAJ Gold
DA 2019-06-25
ER

PT J
AU Rejnmark, L
   Bislev, LS
   Cashman, KD
   Eirisksdottir, G
   Gaksch, M
   Grubler, M
   Grimnes, G
   Gudnason, V
   Lips, P
   Pilz, S
   van Schoor, NM
   Kiely, M
   Jorde, R
AF Rejnmark, Lars
   Bislev, Lise Sofie
   Cashman, Kevin D.
   Eirisksdottir, Gudny
   Gaksch, Martin
   Gruebler, Martin
   Grimnes, Guri
   Gudnason, Vilmundur
   Lips, Paul
   Pilz, Stefan
   van Schoor, Natasja M.
   Kiely, Mairead
   Jorde, Rolf
TI Non-skeletal health effects of vitamin D supplementation: A systematic
   review on findings from meta-analyses summarizing trial data
SO PLOS ONE
LA English
DT Review
ID SERUM 25-HYDROXYVITAMIN D; 3RD NATIONAL-HEALTH; RESPIRATORY-TRACT
   INFECTION; PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIAL;
   IMPAIRED GLUCOSE-TOLERANCE; PARATHYROID-HORMONE LEVELS;
   RENIN-ANGIOTENSIN SYSTEM; D DEFICIENCY; BLOOD-PRESSURE
AB Background
   A large number of observational studies have reported harmful effects of low 25-hydroxyvitamin D (25OHD) levels on non-skeletal outcomes. We performed a systematic quantitative review on characteristics of randomized clinical trials (RCTs) included in meta-analyses (MAs) on non-skeletal effects of vitamin D supplementation.
   Methods and findings
   We identified systematic reviews (SR) reporting summary data in terms of MAs of RCTs on selected non-skeletal outcomes. For each outcome, we summarized the results from available SRs and scrutinized included RCTs for a number of predefined characteristics. We identified 54 SRs including data from 210 RCTs. Most MAs as well as the individual RCTs reported null-findings on risk of cardiovascular diseases, type 2 diabetes, weight-loss, and malignant diseases. Beneficial effects of vitamin D supplementation was reported in 1 of 4 MAs on depression, 2 of 9 MAs on blood pressure, 3 of 7 MAs on respiratory tract infections, and 8 of 12 MAs on mortality. Most RCTs have primarily been performed to determine skeletal outcomes, whereas non-skeletal effects have been assessed as secondary outcomes. Only one-third of the RCTs had low level of 25OHD as a criterion for inclusion and a mean baseline 25OHD level below 50 nmol/L was only present in less than half of the analyses.
   Conclusions
   Published RCTs have mostly been performed in populations without low 25OHD levels. The fact that most MAs on results from RCTs did not show a beneficial effect does not disprove the hypothesis suggested by observational findings on adverse health outcomes of low 25OHD levels.
C1 [Rejnmark, Lars; Bislev, Lise Sofie] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark.
   [Cashman, Kevin D.; Kiely, Mairead] Univ Coll Cork, Sch Food & Nutr Sci, Cork Ctr Vitamin & Nutr Res D, Cork, Ireland.
   [Eirisksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland.
   [Gaksch, Martin; Gruebler, Martin; Pilz, Stefan] Med Univ Graz, Div Endocrinol & Diabetol, Dept Internal Med, Graz, Austria.
   [Gruebler, Martin] Univ Bern, Univ Hosp Bern, Dept Cardiol, Inselspital,Swiss Cardiovasc Ctr Bern, Bern, Switzerland.
   [Grimnes, Guri; Jorde, Rolf] UiT Arctic Univ Norway, Dept Clin Med, Tromso Endocrine Res Grp, Tromso, Norway.
   [Gudnason, Vilmundur] Univ Iceland, Sch Hlth Sci, Fac Med, Reykjavik, Iceland.
   [Lips, Paul] Vrije Univ Amsterdam, Endocrinol Sect, Dept Internal Med, Amsterdam, Netherlands.
   [van Schoor, Natasja M.] Vrije Univ Amsterdam Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Epidemiol & Biostat, Amsterdam, Netherlands.
RP Rejnmark, L (reprint author), Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark.
EM lars.rejnmark@rm.dk
RI Kiely, Mairead/I-8269-2019
OI Kiely, Mairead/0000-0003-0973-808X; Rejnmark, Lars/0000-0002-2152-4247
FU European Community's [613977]
FX This project has received funding from the European Community's Seventh
   Frame work Programme (FP7/2007-2013) under grant ag reement 613977 for
   the ODIN Integrated Project [Food-based solutions for optimal vitamin D
   nutrition and health through the life cycle, http://www.odin-vitd.eu/]
CR Abbas S, 2007, NUTR CANCER, V59, P54, DOI 10.1080/01635580701390223
   Adams JS, 2012, ARCH BIOCHEM BIOPHYS, V523, P95, DOI 10.1016/j.abb.2012.02.016
   Aghajafari F, 2013, BMJ-BRIT MED J, P346
   Antico A, 2012, AUTOIMMUN REV, V12, P127, DOI 10.1016/j.autrev.2012.07.007
   Arvold DS, 2009, ENDOCR PRACT, V15, P203, DOI 10.4158/EP.15.3.203
   Asemi Z, 2013, AM J CLIN NUTR, V98, P1425, DOI 10.3945/ajcn.113.072785
   Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730
   Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7
   Avenell A, 2012, J CLIN ENDOCR METAB, V97, P614, DOI 10.1210/jc.2011-1309
   Avenell A, 2009, AGE AGEING, V38, P606, DOI 10.1093/ageing/afp109
   Barengolts E, 2010, ENDOCR PRACT, V16, P476, DOI 10.4158/EP09195.RA
   Barnard K, 2010, AM J GERIATR PHARMAC, V8, P4, DOI 10.1016/j.amjopharm.2010.02.004
   Bassuk SS, 2016, CONTEMP CLIN TRIALS, V47, P235, DOI 10.1016/j.cct.2015.12.022
   Belcaro G, 2010, PANMINERVA MED, V52, P269
   BELL NH, 1985, J CLIN INVEST, V76, P370, DOI 10.1172/JCI111971
   Bendik I, 2014, FRONT PHYSIOL, P5
   Bergman P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065835
   Berry DJ, 2011, BRIT J NUTR, V106, P1433, DOI 10.1017/S0007114511001991
   Bertone-Johnson ER, 2012, AM J EPIDEMIOL, V176, P1, DOI 10.1093/aje/kwr482
   Beveridge LA, 2015, JAMA INTERN MED, V175, P745, DOI 10.1001/jamainternmed.2015.0237
   Binkley N, 2016, J STEROID BIOCH MOL
   Bjelakovic G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007469.pub2
   Bjelakovic G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub2
   Black LJ, 2014, AUST NZ J PSYCHIAT, V48, P464, DOI 10.1177/0004867413512383
   Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1
   Bland R, 2004, J STEROID BIOCHEM, V89-90, P121, DOI 10.1016/j.jsbmb.2004.03.115
   Bodnar LM, 2007, J NUTR, V137, P447
   Bolland MJ, 2014, LANCET DIABETES ENDO, V2, P307, DOI 10.1016/S2213-8587(13)70212-2
   Bolland MJ, 2011, AM J CLIN NUTR, V94, P1144, DOI 10.3945/ajcn.111.015032
   Brachet P, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P1779
   Brazier M, 2005, CLIN THER, V27, P1885, DOI 10.1016/j.clinthera.2005.12.010
   Brenner H, 2017, J NUTR
   BROOKE OG, 1980, BRIT MED J, V280, P751, DOI 10.1136/bmj.280.6216.751
   Brown JM, 2014, HYPERTENSION, V63, P273, DOI 10.1161/HYPERTENSIONAHA.113.01910
   Bryson KJ, 2014, EPIDEMIOL INFECT, V142, P1789, DOI 10.1017/S0950268814000193
   BUFFINGTON C, 1993, OBES SURG, V3, P421, DOI 10.1381/096089293765559142
   Caan B, 2007, ARCH INTERN MED, V167, P893, DOI 10.1001/archinte.167.9.893
   CADE C, 1986, ENDOCRINOLOGY, V119, P84, DOI 10.1210/endo-119-1-84
   Calton EK, 2017, EUR J CLIN NUTR
   Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175
   Carrillo AE, 2013, CLIN NUTR, V32, P375, DOI 10.1016/j.clnu.2012.08.014
   Cashman KD, 2016, AM J CLIN NUTR, V103, P1033, DOI 10.3945/ajcn.115.120873
   Cashman KD, 2015, SCAND J CLIN LAB INV, V75, P549, DOI 10.3109/00365513.2015.1057898
   Cashman KD, 2014, P NUTR SOC, V73, P65, DOI 10.1017/S0029665113003595
   Cashman KD, 2013, AM J CLIN NUTR, V97, P1235, DOI 10.3945/ajcn.112.057182
   Chandler PD, 2015, NUTR REV, V73, P577, DOI 10.1093/nutrit/nuv012
   Charan J, 2012, J PHARMACOL PHARMACO, V3, P300, DOI 10.4103/0976-500X.103685
   Chen P, 2009, BREAST CANC RES TREA
   Chen WR, 2014, ATHEROSCLEROSIS, V235, P102, DOI 10.1016/j.atherosclerosis.2014.04.011
   CHERTOW BS, 1983, ENDOCRINOLOGY, V113, P1511, DOI 10.1210/endo-113-4-1511
   Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903
   Chowdhury R, 2012, EUR J EPIDEMIOL, V27, P581, DOI 10.1007/s10654-012-9729-z
   Christesen HT, 2012, ACTA OBSTET GYN SCAN, V91, P1357, DOI 10.1111/aogs.12000
   Chung M, 2016, ANN INTERN MED
   Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005
   Chung Mei, 2009, Evid Rep Technol Assess (Full Rep), P1
   Cianferotti L, 2017, ENDOCRINE, V56, P245, DOI 10.1007/s12020-017-1290-9
   Cigolini M, 2006, DIABETES CARE, V29, P722, DOI 10.2337/diacare.29.03.06.dc05-2148
   Das Rashmi Ranjan, 2013, ISRN Pediatr, V2013, P459160, DOI 10.1155/2013/459160
   Davidson MB, 2013, DIABETES CARE, V36, P260, DOI 10.2337/dc12-1204
   de Abreu DAF, 2011, J NEUROL SCI, V311, P64, DOI 10.1016/j.jns.2011.08.044
   de Boer IH, 2008, DIABETES CARE, V31, P701, DOI 10.2337/dc07-1829
   De-Regil LM, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008873.pub3
   De-Regil LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008873.pub2
   Dean AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025966
   Deleskog A, 2012, DIABETOLOGIA, V55, P1668, DOI 10.1007/s00125-012-2529-x
   DeLuca HF, 2014, J ANIM SCI, V92, P917, DOI 10.2527/jas.2013-7237
   Deluca HF, 2001, FASEB J, V15, P2579, DOI 10.1096/fj.01-0433rev
   Dijkstra SH, 2007, ARCH DIS CHILD, V92, P750, DOI 10.1136/adc.2006.105577
   Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340
   Drincic AT, 2012, OBESITY RES
   Dumville JC, 2006, J NUTR HEALTH AGING, V10, P151
   Earthman CP, 2012, INT J OBESITY, V36, P387, DOI 10.1038/ijo.2011.119
   Elamin MB, 2011, J CLIN ENDOCR METAB, V96, P1931, DOI 10.1210/jc.2011-0398
   Engelman CD, 2013, J NUTR, V143, P17, DOI 10.3945/jn.112.169482
   Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006
   Feldman D, 2014, NAT REV CANCER, V14, P342, DOI 10.1038/nrc3691
   Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656
   Ford JA, 2014, AM J CLIN NUTR, V100, P746, DOI 10.3945/ajcn.113.082602
   Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288
   Forman JP, 2013, HYPERTENSION, V61, P779, DOI 10.1161/HYPERTENSIONAHA.111.00659
   Forman JP, 2010, HYPERTENSION, V55, P1283, DOI 10.1161/HYPERTENSIONAHA.109.148619
   Forman JP, 2005, HYPERTENSION, V46, P676, DOI 10.1161/01.HYP.0000182662.82666.37
   Fortmann SP, 2013, ANN INTERN MED, V159, P824, DOI 10.7326/0003-4819-159-12-201312170-00729
   Gaksch M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170791
   Gallagher JC, 2012, ANN INTERN MED, V156, P425, DOI 10.7326/0003-4819-156-6-201203200-00005
   Garcion E, 2002, TRENDS ENDOCRIN MET, V13, P100, DOI 10.1016/S1043-2760(01)00547-1
   George PS, 2012, DIABETIC MED, V29, pE142, DOI 10.1111/j.1464-5491.2012.03672.x
   Gillie O, 2016, PUBLIC HEALTH NUTR, V19, P409, DOI 10.1017/S1368980014002304
   Ginde AA, 2009, CURR ALLERGY ASTHM R, V9, P81, DOI 10.1007/s11882-009-0012-7
   Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560
   Giovannucci E, 2006, J NATL CANCER I, V98, P451, DOI 10.1093/jnei/djj101
   Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174
   GIULIANO AR, 1991, ARCH BIOCHEM BIOPHYS, V285, P261, DOI 10.1016/0003-9861(91)90358-P
   Gloth F M 3rd, 1999, J Nutr Health Aging, V3, P5
   Golzarand M, 2016, NUTR METAB CARDIOVAS, V26, P663, DOI 10.1016/j.numecd.2016.04.011
   Gorham ED, 2005, J STEROID BIOCHEM, V97, P179, DOI 10.1016/j.jsbmb.2005.06.018
   Gorham ED, 2007, AM J PREV MED, V32, P210, DOI 10.1016/j.amepre.2006.11.004
   Gowda U, 2015, NUTRITION, V31, P421, DOI 10.1016/j.nut.2014.06.017
   Grant AM, 2005, LANCET, V365, P1621, DOI 10.1016/S0140-6736(05)63013-9
   Grant WB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176448
   Grubler MR, 2016, J CLIN HYPERTENS
   Gupta AK, 2011, DIABETES CARE, V34, P658, DOI 10.2337/dc10-1829
   Gysin DV, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0162996, 1]
   HADDAD JG, 1993, J CLIN INVEST, V91, P2552, DOI 10.1172/JCI116492
   Halliday GM, 2014, J INVEST DERMATOL, V134, P1791, DOI 10.1038/jid.2014.33
   Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430
   Haroon NN, 2015, J DIABETES METAB DIS, V14, DOI 10.1186/s40200-015-0130-9
   HARRIS S, 1993, PSYCHIAT RES, V49, P77, DOI 10.1016/0165-1781(93)90031-B
   Harvey NC, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18450
   Hashemipour S, 2014, EUR J OBSTET GYN R B, V172, P15, DOI 10.1016/j.ejogrb.2013.10.010
   Heaney RP, 2014, NUTR REV, V72, P48, DOI 10.1111/nure.12090
   HILL AB, 1965, P ROY SOC MED, V58, P295
   Hoffmann MR, 2015, J ACAD NUTR DIET, V115, P406, DOI 10.1016/j.jand.2014.10.023
   Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553
   Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385
   Hollis BW, 2013, J CLIN ENDOCR METAB, V98, P4619, DOI 10.1210/jc.2013-2653
   Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463
   Hoogendijk WJG, 2008, ARCH GEN PSYCHIAT, V65, P508, DOI 10.1001/archpsyc.65.5.508
   Hossain N, 2014, J CLIN ENDOCR METAB, V99, P2448, DOI 10.1210/jc.2013-3491
   Hui S, 2010, SOUTH MED J, V103, P729, DOI 10.1097/SMJ.0b013e3181e6d389
   Hujoel PP, 2013, NUTR REV, V71, P88, DOI 10.1111/j.1753-4887.2012.00544.x
   Hypponen E, 2007, AM J CLIN NUTR, V85, P860
   Ingraham BA, 2008, CURR MED RES OPIN, V24, P139, DOI 10.1185/030079907X253519
   ISHIDA H, 1988, MOL CELL ENDOCRINOL, V60, P109, DOI 10.1016/0303-7207(88)90169-4
   Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218
   Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
   Jaddou HY, 2012, EUR ARCH PSY CLIN N, V262, P321, DOI 10.1007/s00406-011-0265-8
   Jamka M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16142
   Jiang WL, 2016, CLIN CARDIOL, V39, P56, DOI 10.1002/clc.22473
   Jolliffe DA, 2013, J STEROID BIOCHEM, V136, P321, DOI 10.1016/j.jsbmb.2012.11.017
   Jones G, 1998, PHYSIOL REV, V78, P1193
   Jorde R, 2008, J INTERN MED, V264, P599, DOI 10.1111/j.1365-2796.2008.02008.x
   Jorde R, 2006, J NEUROL, V253, P464, DOI 10.1007/s00415-005-0027-5
   Jorde R, 2010, CYTOKINE, V50, P175, DOI 10.1016/j.cyto.2009.12.006
   Jorde R, 2010, HYPERTENSION, V55, P792, DOI 10.1161/HYPERTENSIONAHA.109.143990
   Ju SY, 2013, J NUTR HEALTH AGING, V17, P447, DOI 10.1007/s12603-012-0418-0
   KAMEI Y, 1993, BIOCHEM BIOPH RES CO, V193, P948, DOI 10.1006/bbrc.1993.1717
   Karras SN, 2015, J ENDOCRINOL INVEST, V38, P1265, DOI 10.1007/s40618-015-0363-y
   KAUR J, 1991, NUTR RES, V11, P1077, DOI 10.1016/S0271-5317(05)80400-2
   Kendrick J, 2009, ATHEROSCLEROSIS, V205, P255, DOI 10.1016/j.atherosclerosis.2008.10.033
   Keum N, 2014, BRIT J CANCER, V111, P976, DOI 10.1038/bjc.2014.294
   KHAJAVI A, 1977, CLIN PEDIATR, V16, P36, DOI 10.1177/000992287701600106
   Khajehei M, 2009, INT J GYNECOL OBSTET, V105, P158, DOI 10.1016/j.ijgo.2009.01.016
   Khoraminya N, 2013, AUST NZ J PSYCHIAT, V47, P271, DOI 10.1177/0004867412465022
   Klampfer L, 2014, WORLD J GASTRO ONCOL, V6, P430, DOI 10.4251/wjgo.v6.i11.430
   Knekt P, 2008, EPIDEMIOLOGY, V19, P666, DOI 10.1097/EDE.0b013e318176b8ad
   Krause R, 1998, LANCET, V352, P709, DOI 10.1016/S0140-6736(05)60827-6
   Kristal AR, 2008, CANCER EPIDEM BIOMAR, V17, P3289, DOI 10.1158/1055-9965.EPI-08-1066
   Kroll MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118108
   Kuhlmann A, AM J
   Kull M, 2009, INTERN MED J, V39, P256, DOI 10.1111/j.1445-5994.2009.01900.x
   Kumar GT, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2975
   Kunutsor SK, 2014, EUR J EPIDEMIOL, V29, P1, DOI 10.1007/s10654-013-9874-z
   Kupferschmidt K, 2012, SCIENCE, V337, P1476, DOI 10.1126/science.337.6101.1476
   Laaksi I, 2007, AM J CLIN NUTR, V86, P714
   Lansdowne ATG, 1998, PSYCHOPHARMACOLOGY, V135, P319, DOI 10.1007/s002130050517
   Lappe J, 2017, JAMA-J AM MED ASSOC, V317, P1234, DOI 10.1001/jama.2017.2115
   Lappe JM, 2007, AM J CLIN NUTR, V85, P1586
   Latham NK, 2003, J AM GERIATR SOC, V51, P291, DOI 10.1046/j.1532-5415.2003.51101.x
   Law M, 2006, AGE AGEING, V35, P482, DOI 10.1093/ageing/afj080
   Lazzeroni M, 2013, ANTI-CANCER AGENT ME, V13, P118, DOI 10.2174/187152013804487281
   Lee KJ, 2016, INT J CLIN PHARM TH, V54, P233, DOI 10.5414/CP202493
   Li GW, 2014, J CLIN ENDOCR METAB, V99, P757, DOI 10.1210/jc.2013-3450
   Li GW, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-64
   Li J, 2008, J STEROID BIOCHEM, V112, P122, DOI 10.1016/j.jsbmb.2008.09.006
   Li M, 2014, J CLIN ENDOCR METAB
   Li YC, 2004, J STEROID BIOCHEM, V89-90, P387, DOI 10.1016/j.jsbmb.2004.03.004
   LIEL Y, 1988, CALCIFIED TISSUE INT, V43, P199, DOI 10.1007/BF02555135
   Lips P, 2007, J STEROID BIOCHEM, V103, P620, DOI 10.1016/j.jsbmb.2006.12.076
   Liu D, 2014, J INVEST DERMATOL, V134, P1839, DOI 10.1038/jid.2014.27
   Liu NQ, 2011, J IMMUNOL, V186, P5968, DOI 10.4049/jimmunol.1003332
   Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933
   LJUNGHALL S, 1987, ACTA MED SCAND, V222, P361
   Mahomed K, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000228
   Maki KC, 2011, INT J FOOD SCI NUTR, V62, P318, DOI 10.3109/09637486.2010.536146
   Malaise O, 2007, PREVALENCE VITAMIN D, V23, P1939
   MALLET E, 1986, OBSTET GYNECOL, V68, P300, DOI 10.1097/00006250-198609000-00002
   Manaseki-Holland S, 2012, LANCET, V379, P1419, DOI 10.1016/S0140-6736(11)61650-4
   Mangge H, 2014, WORLD J CARDIOL, V6, P462, DOI 10.4330/wjc.v6.i6.462
   Manousopoulou A, 2015, EUR J CLIN INVEST, V45, P1113, DOI 10.1111/eci.12510
   Manson JE, 2012, CONTEMP CLIN TRIALS, V33, P159, DOI 10.1016/j.cct.2011.09.009
   Mao PJ, 2013, INT J CARDIOL, V169, P106, DOI 10.1016/j.ijcard.2013.08.055
   Mao S, 2013, SCAND J INFECT DIS, V45, P696, DOI 10.3109/00365548.2013.803293
   Martineau AR, 2007, J STEROID BIOCHEM, V103, P793, DOI 10.1016/j.jsbmb.2006.12.052
   Martineau AR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6583
   Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159
   Maruotti N, 2010, J RHEUMATOL, V37, P491, DOI 10.3899/jrheum.090797
   Mason C, 2014, AM J CLIN NUTR, V99, P1015, DOI 10.3945/ajcn.113.073734
   Mattila C, 2007, DIABETES CARE, V30, P2569, DOI 10.2337/dc07-0292
   McCarty MF, 2003, MED HYPOTHESES, V61, P535, DOI 10.1016/S0306-9877(03)00227-5
   Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629
   Melamed ML, 2008, ARTERIOSCL THROM VAS, V28, P1179, DOI 10.1161/ATVBAHA.108.165886
   MERKE J, 1989, J CLIN INVEST, V83, P1903, DOI 10.1172/JCI114097
   MERKE J, 1987, CALCIFIED TISSUE INT, V41, P112, DOI 10.1007/BF02555253
   Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6
   Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118
   Moller UK, 2006, EUR J CLIN NUTR, V60, P1214, DOI 10.1038/sj.ejcn.1602440
   Mosekilde L, 2005, CLIN ENDOCRINOL, V62, P265, DOI 10.1111/j.1365-2265.2005.02226.x
   Moukayed M, 2017, REV ENDOCR METAB DIS, V18, P167, DOI 10.1007/s11154-017-9415-2
   Mozaffari-Khosravi H, 2015, BLOOD PRESS MONIT, V20, P83, DOI 10.1097/MBP.0000000000000091
   Mozaffari-Khosravi H, 2013, J CLIN PSYCHOPHARM, V33, P378, DOI 10.1097/JCP.0b013e31828f619a
   Muscogiuri G, 2014, EUR J ENDOCRINOL, V171, pR101, DOI 10.1530/EJE-14-0158
   Myung SK, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f10
   Nanri A, 2009, EUR J CLIN NUTR, V63, P1444, DOI 10.1038/ejcn.2009.96
   NORMAN AW, 1980, SCIENCE, V209, P823, DOI 10.1126/science.6250216
   Okereke OI, 2016, J AFFECT DISORDERS, V198, P1, DOI 10.1016/j.jad.2016.03.022
   Oplander C, 2009, CIRC RES, V105, P1031, DOI 10.1161/CIRCRESAHA.109.207019
   Pan A, 2009, J AFFECT DISORDERS, V118, P240, DOI 10.1016/j.jad.2009.02.002
   Parikh SJ, 2004, J CLIN ENDOCR METAB, V89, P1196, DOI 10.1210/jc.2003-031398
   Pathak K, 2014, OBES REV, V15, P528, DOI 10.1111/obr.12162
   Patrick RP, 2015, FASEB J, V29, P2207, DOI 10.1096/fj.14-268342
   Perez-Lopez FR, 2015, FERTIL STERIL, V103, P1278, DOI 10.1016/j.fertnstert.2015.02.019
   Pfeifer M, 2001, J CLIN ENDOCR METAB, V86, P1633, DOI 10.1210/jc.86.4.1633
   Pilz S, 2008, J CLIN ENDOCR METAB, V93, P3927, DOI 10.1210/jc.2008-0784
   Pilz S, 2016, ANTICANCER RES, V36, P1379
   Pilz S, 2009, CLIN ENDOCRINOL, V71, P666, DOI 10.1111/j.1365-2265.2009.03548.x
   Pittas AG, 2006, DIABETES CARE, V29, P650, DOI 10.2337/diacare.29.03.06.dc05-1961
   Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298
   Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994
   Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009
   Polak MA, 2014, NUTRIENTS, V6, P4720, DOI 10.3390/nu6114720
   Pourshahidi LK, 2014, P NUTR SOC
   Prince RL, 2008, ARCH INTERN MED, V168, P103, DOI 10.1001/archinternmed.2007.31
   Querfeld U, 1999, J AM SOC NEPHROL, V10, P2158
   Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227
   Rejnmark L, 2012, J CLIN ENDOCR METAB, V97, P2670, DOI 10.1210/jc.2011-3328
   RESNICK LM, 1986, FASEB J, V45, P2739
   Riek AE, 2010, J STEROID BIOCHEM, V121, P430, DOI 10.1016/j.jsbmb.2010.03.018
   Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000
   Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704
   Roth DE, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-47
   Sabetta JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011088
   Sablok A, 2015, CLIN ENDOCRINOL, V83, P536, DOI 10.1111/cen.12751
   Sackett DL, 1996, BRIT MED J, V312, P71
   Salehpour A, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-78
   Sanders KM, 2011, BRIT J PSYCHIAT, V198, P357, DOI 10.1192/bjp.bp.110.087544
   Sarafin K, 2015, AM J CLIN NUTR, V102, P1044, DOI 10.3945/ajcn.114.103689
   Schnatz PF, 2014, CLIN CHEM, V60, P600, DOI 10.1373/clinchem.2013.211037
   Schnatz PF, 2012, MENOPAUSE, V19, P1074, DOI 10.1097/gme.0b013e31825499f0
   Schneider B, 2000, J NEURAL TRANSM, V107, P839, DOI 10.1007/s007020070063
   Science M, 2013, CLIN INFECT DIS, V57, P392, DOI 10.1093/cid/cit289
   Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.2813
   Scragg R, 2017, JAMA CARDIOLOGY
   Seida JC, 2014, J CLIN ENDOCR METAB, V99, P3551, DOI 10.1210/jc.2014-2136
   Sempos CT, 2017, OSTEOPOROSIS INT, V28, P1503, DOI 10.1007/s00198-017-3978-3
   Shaffer JA, 2014, PSYCHOSOM MED, V76, P190, DOI 10.1097/PSY.0000000000000044
   Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10
   Shea BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001350
   Shin JS, 2010, PLACENTA, V31, P1027, DOI 10.1016/j.placenta.2010.08.015
   Slomian J, 2014, PREVALENCE VITAMIN D, V59, P78
   Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875
   Smedby KE, 2005, JNCI-J NATL CANCER I, V97, P199, DOI 10.1093/jnci/dji022
   Sneve M, 2008, EUR J ENDOCRINOL, V159, P675, DOI 10.1530/EJE-08-0339
   Soares MJ, 2011, EUR J CLIN NUTR, V65, P994, DOI 10.1038/ejcn.2011.106
   Sokol SI, 2011, CARDIOL REV, V19, P192, DOI 10.1097/CRD.0b013e31821da9a5
   Souberbielle JC, 2010, AUTOIMMUN REV, V9, P709, DOI 10.1016/j.autrev.2010.06.009
   Spedding S, 2014, NUTRIENTS, V6, P1501, DOI 10.3390/nu6041501
   Sperati F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069269
   Sugden JA, 2008, DIABETIC MED, V25, P320, DOI 10.1111/j.1464-5491.2007.02360.x
   Tabesh M, 2014, DIABETOLOGIA, V57, P2038, DOI 10.1007/s00125-014-3313-x
   Talmor Y, 2008, EUR J CLIN INVEST, V38, P548, DOI 10.1111/j.1365-2362.2008.01977.x
   Talmor Y, 2008, AM J PHYSIOL-RENAL, V294, pF1059, DOI 10.1152/ajprenal.00051.2008
   Targher G, 2006, CLIN ENDOCRINOL, V65, P593, DOI 10.1111/j.1365-2265.2006.02633.x
   Theodoratou E, 2014, BMJ-BRIT MED J, P348
   Thorne-Lyman A, 2012, PAEDIATR PERINAT EP, V26, P75, DOI 10.1111/j.1365-3016.2012.01283.x
   Tomaschitz A, 2014, METABOLISM, V63, P20, DOI 10.1016/j.metabol.2013.08.016
   Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469
   Upala S, 2016, SCAND CARDIOVASC J, V50, P230, DOI 10.3109/14017431.2016.1173226
   van Schoor NM, 2011, BEST PRACT RES CL EN, V25, P671, DOI 10.1016/j.beem.2011.06.007
   VANDERWIELEN RPJ, 1995, LANCET, V346, P207, DOI 10.1016/S0140-6736(95)91266-5
   Veloudi P, 2016, PULSE, V4, P193, DOI 10.1159/000452742
   Vieth R, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-8
   Vimaleswaran KS, 2014, LANCET DIABETES ENDO, V2, P719, DOI 10.1016/S2213-8587(14)70113-5
   Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383
   Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222
   WAKASUGI M, 1991, PROSTAG OTH LIPID M, V42, P127, DOI 10.1016/0090-6980(91)90072-N
   Wamberg L, 2013, EUR J INTERN MED, V24, P644, DOI 10.1016/j.ejim.2013.03.005
   Wang L, 2012, CIRC-CARDIOVASC QUAL, V5, P819, DOI 10.1161/CIRCOUTCOMES.112.967604
   Wang L, 2010, ANN INTERN MED, V152, P315, DOI 10.7326/0003-4819-152-5-201003020-00010
   Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909
   Wei SQ, 2013, J MATERN-FETAL NEO M, V26, P889, DOI 10.3109/14767058.2013.765849
   White JH, 2012, REV ENDOCR METAB DIS, V13, P21, DOI 10.1007/s11154-011-9195-z
   Wilkins CH, 2006, AM J GERIAT PSYCHIAT, V14, P1032, DOI 10.1097/01.JGP.0000240986.74642.7c
   Wimalawansa SJ, 2016, J STEROID BIOCH MOL
   WION D, 1991, J NEUROSCI RES, V28, P110, DOI 10.1002/jnr.490280111
   Witham MD, 2013, JAMA INTERN MED, V173, P1672, DOI 10.1001/jamainternmed.2013.9043
   Witham MD, 2009, J HYPERTENS, V27, P1948, DOI 10.1097/HJH.0b013e32832f075b
   Wortsman J, 2000, AM J CLIN NUTR, V72, P690
   Wu-Wong JR, 2007, J CELL BIOCHEM, V100, P1395, DOI 10.1002/jcb.21133
   Wu-Wong JR, 2007, J VASC RES, V44, P11, DOI 10.1159/000097812
   Xiao LM, 2015, BRIT J NUTR, V114, P1026, DOI 10.1017/S000711451500207X
   Xu YQ, 2014, TUMOR BIOL, V35, P4153, DOI 10.1007/s13277-013-1544-y
   Yakoob MY, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008824.pub2
   Yalamanchili V, 2012, MENOPAUSE, V19, P697, DOI 10.1097/gme.0b013e31823bcec5
   Yamshchikov AV, 2009, ENDOCR PRACT, V15, P438, DOI 10.4158/EP09101.ORR
   Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888
   Zhang M, 2011, NUTRITION, V27, P530, DOI 10.1016/j.nut.2010.05.016
   Zhao GX, 2010, BRIT J NUTR, V104, P1696, DOI 10.1017/S0007114510002588
   Zheng YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115850
   Zheng YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082109
   Zittermann A, 2017, EUR HEART J, V38, P2279, DOI 10.1093/eurheartj/ehx235
   Zittermann A, 2009, AM J CLIN NUTR, V89, P1321, DOI 10.3945/ajcn.2008.27004
NR 303
TC 41
Z9 42
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 7
PY 2017
VL 12
IS 7
AR e0180512
DI 10.1371/journal.pone.0180512
PG 39
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FA5DZ
UT WOS:000405464100072
PM 28686645
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Chirita-Emandi, A
   Socolov, D
   Haivas, C
   Calapis, A
   Gheorghiu, C
   Puiu, M
AF Chirita-Emandi, Adela
   Socolov, Demetra
   Haivas, Carmen
   Calapis, Anca
   Gheorghiu, Cristina
   Puiu, Maria
TI Vitamin D Status: A Different Story in the Very Young versus the Very
   Old Romanian Patients
SO PLOS ONE
LA English
DT Article
ID BONE-MINERAL DENSITY; D DEFICIENCY; PARATHYROID-HORMONE;
   25-HYDROXYVITAMIN D; D SUPPLEMENTATION; CALCIUM; ADOLESCENTS; CHILDREN
AB Background
   In Romania (latitude 48 degrees 15'N to 43 degrees 40'N), vitamin D supplementation is common practice mostly in infants 0-1 year old. No published information is available regarding epidemiological data on vitamin D status in the Romanian population for a wide age range and geographical territory. In this context, we aimed to evaluate the seasonal and age variation of vitamin D status in a large Romanian population.
   Methods
   6631 individuals from across Romania had performed 7544 vitamin D assessments (20122014) in a chain of private laboratories. Vitamin D (25-hydroxyvitamin D2 and 25-hydroxyvitamin D3) was measured using High Performance Liquid Chromatography. Vitamin D levels were classified as severe deficiency<10ng/mL, deficiency 10-20ng/mL, insufficiency 2129ng/mL, sufficiency >= 30ng/mL and potentially harmful>100ng/ml.
   Results
   Male to female ratio was 1: 2.9. Age ranged from 0 to 85 years. Mean vitamin D levels increased from April (26.3ng/ml) to September (35.6ng/ml) and decreased from October (33.5ng/ml) to March (24.4ng/ml). Overall 40% had sufficient vitamin D, while the rest were insufficient 33%, deficient 22%, severely deficient 4% and 1% potentially harmful (of them 81% under 1 year old). Males compared to females showed higher percentages of sufficiency (47% vs. 38%). Children 0-2 years presented the highest percentage of vitamin D sufficiency (77%). Lowest percentages (21%) of sufficiency were in people 80-84 years.
   Conclusion
   In Romania, suboptimal vitamin D levels are common (59%), especially in older age, wintertime and in women. Vitamin D supplementation would be most warranted from January to April in the Romanian population. 25-hydroxyvitamin D levels>100ng/ml were relatively prevalent in children 0-1 year old (17.3%). This was attributed to supplementation errors and the fact that high-risk individuals were more likely to visit for medical check-up. Nonetheless, it stresses the need to increase awareness of the importance of preventing Vitamin D supplementation administration errors in the young.
C1 [Chirita-Emandi, Adela; Gheorghiu, Cristina; Puiu, Maria] Univ Med & Farm Timisoara, Dept Genet, Timisoara, Romania.
   [Socolov, Demetra] Univ Med & Pharm Gr T Popa, Ginecol Dept, Iasi, Romania.
   [Haivas, Carmen] Univ Med & Farm Timisoara, Dept Anat, Timisoara, Romania.
   [Calapis, Anca] Bioclin Lab SA, Timisoara, Romania.
   [Puiu, Maria] Clin Emergency Hosp Children Louis Turcanu, Dept Genet, Timisoara, Romania.
RP Chirita-Emandi, A (reprint author), Univ Med & Farm Timisoara, Dept Genet, Timisoara, Romania.
EM adela.chirita@umft.ro
RI Chirita-Emandi, Adela/G-5574-2016; Puiu, Maria/F-3138-2016
OI Chirita-Emandi, Adela/0000-0001-7554-4625; 
FU Human Resources Development Operational Programme
   [POSDRU/159/1.5/136893]; Center of Genomic Medicine from the University
   of Medicine and Pharmacy "Victor Babes" Timisoara
   [POSCCE-A2O2.2.1-2013-1]; Bioclinica Laboratoarele
FX Chirita-Emandi Adela is a Postdoctoral fellow under the frame of
   European Social Fund, Human Resources Development Operational Programme
   2007-2013, project no. POSDRU/159/1.5/136893. Maria Puiu was funded
   under Operational program: Development of existing infrastructure and
   creation of new infrastructure (laboratories, research centers).
   POSCCE-A2O2.2.1-2013-1, in the Center of Genomic Medicine from the
   University of Medicine and Pharmacy "Victor Babes" Timisoara. These
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. All other authors
   received no specific funding for this work. Coauthor Anca CalapiS is
   employed by Bioclinica Laboratoarele, SA. Bioclinica Laboratoarele
   provided support in the form of salary for author AC, but did not have
   any additional role in the study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. The specific role
   of this author is articulated in the 'author contributions' section.
CR Absoud M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022179
   [Anonymous], 2014, REV MED CHIR SOC MED
   Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730
   Avenell A, 2007, AGE AGEING, V36, P574, DOI 10.1093/ageing/afm091
   Azab SFA, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-73
   Bener A, 2014, J FAM COMMUNITY MED, V21, P154, DOI 10.4103/2230-8229.142967
   Braegger C, 2013, J PEDIATR GASTR NUTR, V56, P692, DOI 10.1097/MPG.0b013e31828f3c05
   Bruyere O, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-32
   Daly RM, 2012, CLIN ENDOCRINOL, V77, P26, DOI 10.1111/j.1365-2265.2011.04320.x
   de Wildt SN, 2014, ARCH DIS CHILD, V99, P1137, DOI 10.1136/archdischild-2013-305212
   Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340
   Dumitrescu G, 2013, MED-SURG J, V117, P23
   El-Hajj Fuleihan G, 2006, J CLIN ENDOCR METAB, V91, P405, DOI 10.1210/jc.2005-1436
   Fodor D, 2014, ACTA PHYSIOL HUNG, V101, P216, DOI 10.1556/APhysiol.101.2014.2.10
   GARLAND CF, 1989, LANCET, V2, P1176
   Gill RS, 2012, CAN J SURG, V55, P239, DOI 10.1503/cjs.035710
   Gill TK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1001
   Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604
   Gonzalez-Gross M, 2012, BRIT J NUTR, V107, P755, DOI 10.1017/S0007114511003527
   Gradinaru D, 2012, AGING CLIN EXP RES, V24, P595, DOI 10.3275/8591
   Grundmann M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-146
   Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385
   Hunt K, 2011, J HEALTH SERV RES PO, V16, P108, DOI 10.1258/jhsrp.2010.009131
   Huss L, 2014, CANCER CAUSE CONTROL, V25, P1131, DOI 10.1007/s10552-014-0413-3
   Jacques PF, 1997, AM J CLIN NUTR, V66, P929
   Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477
   Looker AC, 2011, NCHS DATA BRIEF, V59, P1
   MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134
   Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC
   McCullough ML, 2010, AM J EPIDEMIOL, V172, P21, DOI 10.1093/aje/kwq113
   Mocanu V, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-137
   Pludowski P, 2014, INT J ENDOCRINOL, DOI 10.1155/2014/589587
   Poole KES, 2006, STROKE, V37, P243, DOI 10.1161/01.STR.0000195184.24297.c1
   Porojnicu AC, 2012, PUBLIC HEALTH NUTR, V15, P2157, DOI 10.1017/S1368980012000158
   Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704
   Smith GR, 2005, J RHEUMATOL, V32, P684
   Steingrimsdottir L, 2005, JAMA-J AM MED ASSOC, V294, P2336, DOI 10.1001/jama.294.18.2336
   Vierucci F, 2013, EUR J PEDIATR, V172, P1607, DOI 10.1007/s00431-013-2119-z
   Villamor E, 2011, AM J CLIN NUTR, V94, P1020, DOI 10.3945/ajcn.111.018168
NR 39
TC 7
Z9 7
U1 1
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 29
PY 2015
VL 10
IS 5
AR UNSP e0128010
DI 10.1371/journal.pone.0128010
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CJ2MQ
UT WOS:000355319400063
PM 26024516
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Zheng, YT
   Cui, QQ
   Hong, YM
   Yao, WG
AF Zheng, Ya Ting
   Cui, Qi Qi
   Hong, Yi Min
   Yao, Wei Guang
TI A Meta-Analysis of High Dose, Intermittent Vitamin D Supplementation
   among Older Adults
SO PLOS ONE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIALS; PLACEBO-CONTROLLED TRIAL; ORAL
   VITAMIN-D-3; DOUBLE-BLIND; CALCIUM SUPPLEMENTATION; RESIDENTIAL CARE;
   POOLED ANALYSIS; FALLS; PEOPLE; FRACTURES
AB Background
   The effects of intermittent, high dose vitamin D treatment in older adults have not been documented. We conducted a meta-analysis to provide a quantitative assessment of the efficiency of intermittent, high dose vitamin D treatment on falls, fractures, and mortality among older adults.
   Methods
   Electronic databases were searched for randomized controlled trials (RCTs) on high dose, intermittent vitamin D supplementation among older adults. Two researchers independently screened the literature according to specified inclusive and exclusive criteria to extract the data. Meta-analysis was performed by using Review Manager 5.1.0 software.
   Results
   Nine trials were included in this meta-analysis. High dose, intermittent vitamin D therapy did not decrease all-cause mortality among older adults. The risk ratio (95% CI) was 1.04 (0.91-1.17). No benefit was seen in fracture or fall prevention. The risk ratio for hip fractures (95% CI) was 1.17 (0.97-1.41) while for non-vertebral fractures (95% CI) it was 1.06 (0.91-1.22), and the risk ratio for falls (95% CI) was 1.02 (0.96-1.08). Results remained robust after sensitivity analysis.
   Conclusion
   Supplementation of intermittent, high dose vitamin D may not be effective in preventing overall mortality, fractures, or falls among older adults. The route of administration of vitamin D supplements may well change the physiological effects.
C1 [Zheng, Ya Ting; Cui, Qi Qi; Hong, Yi Min; Yao, Wei Guang] Soouthern Med Univ, Coll Humanities & Management, Guangzhou, Guangdong, Peoples R China.
RP Yao, WG (reprint author), Soouthern Med Univ, Coll Humanities & Management, Guangzhou, Guangdong, Peoples R China.
EM yaoweiguang2014@yeah.net
CR Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730
   Bacon CJ, 2009, OSTEOPOROSIS INT, V20, P1407, DOI 10.1007/s00198-008-0814-9
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Bischoff HA, 2003, J BONE MINER RES, V18, P343, DOI 10.1359/jbmr.2003.18.2.343
   Bischoff-Ferrari HA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3692
   Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617
   Bjelakovic G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub2
   Buell JS, 2008, MOL ASPECTS MED, V29, P415, DOI 10.1016/j.mam.2008.05.001
   Chung Mei, 2009, Evid Rep Technol Assess (Full Rep), P1
   Dhesi JK, 2004, AGE AGEING, V33, P589, DOI 10.1093/ageing/afh209
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Flicker L, 2005, J AM GERIATR SOC, V53, P1881, DOI 10.1111/j.1532-5415.2005.00468.x
   Glendenning P, 2012, J BONE MINER RES, V27, P170, DOI 10.1002/jbmr.524
   Harwood RH, 2004, AGE AGEING, V33, P45, DOI 10.1093/ageing/afh002
   HIGGINS JPT, 2008, COCHRANE HDB SYSTEMA
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Hollis BW, 2013, J CLIN ENDOCR METAB, V98, P4619, DOI 10.1210/jc.2013-2653
   Latham NK, 2003, J AM GERIATR SOC, V51, P291, DOI 10.1046/j.1532-5415.2003.51101.x
   Law M, 2006, AGE AGEING, V35, P482, DOI 10.1093/ageing/afj080
   Lyons RA, 2007, OSTEOPOROSIS INT, V18, P811, DOI 10.1007/s00198-006-0309-5
   Murad MH, 2011, J CLIN ENDOCR METAB, V96, P2997, DOI 10.1210/jc.2011-1193
   Pfeifer M, 2009, OSTEOPOROSIS INT, V20, P315, DOI 10.1007/s00198-008-0662-7
   Prince RL, 2008, ARCH INTERN MED, V168, P103, DOI 10.1001/archinternmed.2007.31
   Rejnmark L, 2012, J CLIN ENDOCR METAB, V97, P2670, DOI 10.1210/jc.2011-3328
   Rossini M, 2012, J CLIN ENDOCR METAB, V97, pE622, DOI 10.1210/jc.2011-2448
   Sanders KM, 2013, CALCIFIED TISSUE INT, V92, P191, DOI 10.1007/s00223-012-9679-1
   Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594
   Smith H, 2007, RHEUMATOLOGY, V46, P1852, DOI 10.1093/rheumatology/kem240
   The DIPART Group, 2010, BMJ-BRIT MED J, V340, pb5463, DOI DOI 10.1136/BMJ.B5463
   Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469
   van den Bergh Joop P W, 2011, Curr Osteoporos Rep, V9, P36, DOI 10.1007/s11914-010-0041-0
   Wahl D A, 2012, Arch Osteoporos, V7, P155, DOI 10.1007/s11657-012-0093-0
   Wigg AER, 2006, MED J AUSTRALIA, V185, P195
NR 33
TC 19
Z9 19
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 20
PY 2015
VL 10
IS 1
AR e0115850
DI 10.1371/journal.pone.0115850
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AZ4OZ
UT WOS:000348203500017
PM 25602255
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Roy, S
   Shrinivas, K
   Bagchi, B
AF Roy, Susmita
   Shrinivas, Krishna
   Bagchi, Biman
TI A Stochastic Chemical Dynamic Approach to Correlate Autoimmunity and
   Optimal Vitamin-D Range
SO PLOS ONE
LA English
DT Article
ID REGULATORY T-CELLS; D ENDOCRINE SYSTEM; DENDRITIC CELLS; D-RECEPTOR;
   25-HYDROXYVITAMIN D-3; IMMUNE-SYSTEM; DIFFERENTIATION; ACTIVATION;
   EXPRESSION; SUBPOPULATIONS
AB Motivated by several recent experimental observations that vitamin-D could interact with antigen presenting cells (APCs) and T-lymphocyte cells (T-cells) to promote and to regulate different stages of immune response, we developed a coarse grained but general kinetic model in an attempt to capture the role of vitamin-D in immunomodulatory responses. Our kinetic model, developed using the ideas of chemical network theory, leads to a system of nine coupled equations that we solve both by direct and by stochastic (Gillespie) methods. Both the analyses consistently provide detail information on the dependence of immune response to the variation of critical rate parameters. We find that although vitamin-D plays a negligible role in the initial immune response, it exerts a profound influence in the long term, especially in helping the system to achieve a new, stable steady state. The study explores the role of vitamin-D in preserving an observed bistability in the phase diagram (spanned by system parameters) of immune regulation, thus allowing the response to tolerate a wide range of pathogenic stimulation which could help in resisting autoimmune diseases. We also study how vitamin-D affects the time dependent population of dendritic cells that connect between innate and adaptive immune responses. Variations in dose dependent response of anti-inflammatory and pro-inflammatory T-cell populations to vitamin-D correlate well with recent experimental results. Our kinetic model allows for an estimation of the range of optimum level of vitamin-D required for smooth functioning of the immune system and for control of both hyper-regulation and inflammation. Most importantly, the present study reveals that an overdose or toxic level of vitamin-D or any steroid analogue could give rise to too large a tolerant response, leading to an inefficacy in adaptive immune function.
C1 [Roy, Susmita; Shrinivas, Krishna; Bagchi, Biman] Indian Inst Sci, SSCU, Bangalore 560012, Karnataka, India.
RP Bagchi, B (reprint author), Indian Inst Sci, SSCU, Bangalore 560012, Karnataka, India.
EM profbiman@gmail.com
OI Shrinivas, Krishna/0000-0002-4167-9385; BAGCHI,
   BIMAN/0000-0002-7146-5994
FU Department of Science and Technology (DST), India; Sir J.C. Bose
   Fellowship (DST)
FX This work was supported in parts by grants from Department of Science
   and Technology (DST), India and Sir J.C. Bose Fellowship (DST). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Adorini L, 2005, CELL IMMUNOL, V233, P115, DOI 10.1016/j.cellimm.2005.04.013
   Adorini L, 2003, ANN NY ACAD SCI, V987, P258, DOI 10.1111/j.1749-6632.2003.tb06057.x
   Alberts B., 2002, MOL BIOL CELL
   Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730
   Bates MF, 2014, PEDIATRICS, V133, pE39, DOI 10.1542/peds.2013-2418
   Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454
   Chaudhury S, 2013, J PHYS CHEM B, V117, P503, DOI 10.1021/jp3096659
   Christen U, 2004, CURR OPIN IMMUNOL, V16, P759, DOI 10.1016/j.coi.2004.09.002
   Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033
   Cutolo M, 2011, AUTOIMMUN REV, V11, P84, DOI 10.1016/j.autrev.2011.08.003
   Cutolo M, 2011, VITAM HORM, V86, P327, DOI 10.1016/B978-0-12-386960-9.00014-9
   Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051
   de Pillis L, 2013, DISCRETE CONT DYN-B, V18, P915, DOI 10.3934/dcdsb.2013.18.915
   Dimeloe S, 2010, J STEROID BIOCHEM, V120, P86, DOI 10.1016/j.jsbmb.2010.02.029
   Fearnley DB, 1999, BLOOD, V93, P728
   Finsen NR, 1903, COUNT KAH MORN RECT
   Fleet JC, 2004, J NUTR, V134, P3215
   Fouchet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002306
   Ghosh S, 2012, EUR PHYS J E, V35, DOI 10.1140/epje/i2012-12011-4
   GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3
   Gregori S, 2001, J IMMUNOL, V167, P1945, DOI 10.4049/jimmunol.167.4.1945
   Harris SS, 2005, J NUTR, V135, P323
   Hewison M, 2012, CLIN ENDOCRINOL, V76, P315, DOI 10.1111/j.1365-2265.2011.04261.x
   Hewison M, 2011, VITAM HORM, V86, P23, DOI 10.1016/B978-0-12-386960-9.00002-2
   Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553
   Hong T, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-66
   HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135
   Hypponen E, 2009, ALLERGY, V64, P613, DOI 10.1111/j.1398-9995.2008.01865.x
   Jeffery LE, 2012, J IMMUNOL, V189, P5155, DOI 10.4049/jimmunol.1200786
   JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373
   Jones G, 2012, ARCH BIOCHEM BIOPHYS, V523, P9, DOI 10.1016/j.abb.2011.11.003
   Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213
   Jonuleit H, 2001, TRENDS IMMUNOL, V22, P394, DOI 10.1016/S1471-4906(01)01952-4
   Kamen D, 2008, CURR OPIN RHEUMATOL, V20, P532, DOI 10.1097/BOR.0b013e32830a991b
   Kamen DL, 2010, J MOL MED, V88, P441, DOI 10.1007/s00109-010-0590-9
   Leon K, 2000, J THEOR BIOL, V207, P231, DOI 10.1006/jtbi.2000.2169
   LIGTHART GJ, 1985, IMMUNOLOGY, V55, P15
   Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X
   Lo WC, 2013, B MATH BIOL, V75, P1417, DOI 10.1007/s11538-013-9853-2
   Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0
   Mandlik V, 2012, INTEGR BIOL-UK, V4, P1130, DOI 10.1039/c2ib20037f
   Martinez-Pasamar S, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-34
   Min W, 2008, J PHYS CHEM B, V112, P454, DOI 10.1021/jp076533c
   Min W, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3207274
   Moller KI, 2005, PHOTODERMATOL PHOTO, V21, P118, DOI 10.1111/j.1600-0781.2005.00159.x
   Moyad MA, 2009, DERMATOLOGY NURSING, V21, P1
   Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745
   Peelen E, 2011, AUTOIMMUN REV, V10, P733, DOI 10.1016/j.autrev.2011.05.002
   Penna G, 2005, BLOOD, V106, P3490, DOI 10.1182/blood-2005-05-2044
   Piemonti L, 2000, J IMMUNOL, V164, P4443, DOI 10.4049/jimmunol.164.9.4443
   Pike JW, 2012, REV ENDOCR METAB DIS, V13, P45, DOI 10.1007/s11154-011-9198-9
   Powrie F, 2003, SCIENCE, V299, P1030, DOI 10.1126/science.1082031
   Qian H, 2003, BIOPHYS CHEM, V105, P585, DOI 10.1016/S0301-4622(03)00068-1
   Qian H, 2009, PHYS CHEM CHEM PHYS, V11, P4861, DOI 10.1039/b900335p
   Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704
   Ross AC, 2011, Dietary Reference Intakes for Calcium and Vitamin D, P1
   SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151
   Sanders KM, 2013, CALCIFIED TISSUE INT, V92, P191, DOI 10.1007/s00223-012-9679-1
   Santra M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066112
   Santra M, 2012, J PHYS CHEM B, V116, P11809, DOI 10.1021/jp305045w
   Sasmal DK, 2013, LANGMUIR, V29, P2289, DOI 10.1021/la3043473
   Schuster I, 2006, ANTICANCER RES, V26, P2653
   Stolzenberg-Solomon RZ, 2010, AM J EPIDEMIOL, V172, P81, DOI 10.1093/aje/kwq120
   Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827
   Turner TE, 2004, COMPUT BIOL CHEM, V28, P165, DOI 10.1016/j.compbiolchem.2004.05.001
   von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851
   Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909
   Whitmire JK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000041
   Wilhelm T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-90
   Williams CJB, 1849, LONDON J MED, V1, P1
   Wu ZH, 2012, BIOPHYS J, V103, P1052, DOI 10.1016/j.bpj.2012.08.008
NR 71
TC 4
Z9 4
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 27
PY 2014
VL 9
IS 6
AR e100635
DI 10.1371/journal.pone.0100635
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AK6BK
UT WOS:000338512200047
PM 24971516
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Lambert, AA
   Drummond, MB
   Mehta, SH
   Brown, TT
   Lucas, GM
   Kirk, GD
   Estrella, MM
AF Lambert, Allison A.
   Drummond, M. Bradley
   Mehta, Shruti H.
   Brown, Todd T.
   Lucas, Gregory M.
   Kirk, Gregory D.
   Estrella, Michelle M.
TI Risk Factors for Vitamin D Deficiency among HIV-Infected and Uninfected
   Injection Drug Users
SO PLOS ONE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; RESPIRATORY-TRACT INFECTION; BONE-MINERAL
   DENSITY; CHRONIC HEPATITIS-C; D SUPPLEMENTATION; CALCIUM
   SUPPLEMENTATION; SEASONAL-VARIATION; D INSUFFICIENCY; UNITED-STATES;
   CUTANEOUS SYNTHESIS
AB Introduction: Vitamin D deficiency is highly prevalent and is associated with bone disease, cardiovascular disease, metabolic syndrome and malignancy. Injection drug users (IDUs), with or without HIV infection, are at risk for these conditions; however, limited data on vitamin D deficiency exist in this population. We determined the prevalence and correlates of vitamin D deficiency among urban IDUs in the AIDS Linked to the IntraVenous Experience (ALIVE) Study cohort.
   Methods: For this cross-sectional sub-study, vitamin D deficiency was defined as a serum 25(OH)-vitamin D level <20 ng/mL. Multivariable logistic regression was used to identify factors independently associated with vitamin D deficiency.
   Results: Of 950 individuals analyzed, 29% were HIV-infected. The median age was 49 years; 65% were male, and 91% were black. The median vitamin D level was 13.5 ng/mL (IQR, 9.0-20.3); 74% were deficient (68% in HIV-infected vs. 76% in HIV-uninfected, p = 0.01). Non-black race, fall/winter season, multivitamin intake, higher serum albumin, HCV seropositivity and HIV-infection were associated with significantly lower odds of vitamin D deficiency.
   Conclusions: Vitamin D deficiency is prevalent among IDUs. Notably, HIV-infected IDUs were less likely to be vitamin D deficient. Higher vitamin D levels were associated with multivitamin intake and with higher albumin levels, suggesting that nutritional status contributes substantially to deficiency. The association between HCV serostatus and vitamin D level remains unclear. Further investigation is needed to define the clinical implications of the heavy burden of vitamin D deficiency in this high-risk, aging population with significant co-morbidities.
C1 [Lambert, Allison A.; Drummond, M. Bradley] Johns Hopkins Univ, Dept Med, Div Pulm & Crit Care, Baltimore, MD 21218 USA.
   [Mehta, Shruti H.; Kirk, Gregory D.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA.
   [Brown, Todd T.] Johns Hopkins Univ, Dept Med, Div Endocrinol & Metab, Baltimore, MD USA.
   [Lucas, Gregory M.; Kirk, Gregory D.] Johns Hopkins Univ, Dept Med, Div Infect Dis, Baltimore, MD USA.
   [Estrella, Michelle M.] Johns Hopkins Univ, Dept Med, Div Nephrol, Baltimore, MD USA.
RP Lambert, AA (reprint author), Johns Hopkins Univ, Dept Med, Div Pulm & Crit Care, Baltimore, MD 21218 USA.
EM alamber5@jhmi.edu
FU National Institutes of Health, National Institute on Drug Abuse (NIDA)
   [R01-DA-04334, R01-DA-12568]; Tufts University Nutrition Collaborative;
   Center for Drug Abuse and AIDS Research; NIDA [P30 DA13868, P30
   AI094189, K24 DA035684, R01-DA-026770]
FX This work was funded by the National Institutes of Health, National
   Institute on Drug Abuse (NIDA) Grants R01-DA-04334 and R01-DA-12568 and
   also by NIDA Grant P30 DA13868, P30 AI094189 and K24 DA035684, the Tufts
   University Nutrition Collaborative and the Center for Drug Abuse and
   AIDS Research. GML is supported by NIDA Grant R01-DA-026770. The content
   is solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institutes of Health. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Adeyemi OM, 2011, JAIDS-J ACQ IMM DEF, V57, P197, DOI 10.1097/QAI.0b013e31821ae418
   Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027
   Annweiler C, 2009, J NUTR HEALTH AGING, V13, P893, DOI 10.1007/s12603-009-0248-x
   Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730
   Bailey BA, 2012, J RURAL HEALTH, V28, P356, DOI 10.1111/j.1748-0361.2012.00407.x
   Binswanger IA, 2000, CLIN INFECT DIS, V30, P579, DOI 10.1086/313703
   Bischoff HA, 2003, J BONE MINER RES, V18, P343, DOI 10.1359/jbmr.2003.18.2.343
   Bischoff-Ferrari HA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3692
   Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999
   Bolland MJ, 2007, AM J CLIN NUTR, V86, P959
   BOUILLON R, 1984, J CLIN ENDOCR METAB, V59, P86, DOI 10.1210/jcem-59-1-86
   Celentano DD, 2001, AIDS, V15, P1707, DOI 10.1097/00002030-200109070-00015
   Chen TC, 2007, ARCH BIOCHEM BIOPHYS, V460, P213, DOI 10.1016/j.abb.2006.12.017
   CHERUBIN CE, 1993, ANN INTERN MED, V119, P1017, DOI 10.7326/0003-4819-119-10-199311150-00009
   CLEMENS TL, 1982, LANCET, V1, P74
   Compher CW, 2008, OBES SURG, V18, P220, DOI 10.1007/s11695-007-9289-6
   Compton WM, 2007, ARCH GEN PSYCHIAT, V64, P566, DOI 10.1001/archpsyc.64.5.566
   Daly RM, 2006, J BONE MINER RES, V21, P397, DOI 10.1359/JBMR.051206
   Dao CN, 2011, CLIN INFECT DIS, V52, P396, DOI 10.1093/cid/ciq158
   DAWSONHUGHES B, 1990, NEW ENGL J MED, V323, P878, DOI 10.1056/NEJM199009273231305
   Deiss RG, 2009, CLIN INFECT DIS, V48, P72, DOI 10.1086/594126
   Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x
   Ebright JR, 2002, INFECT DIS CLIN N AM, V16, P697, DOI 10.1016/S0891-5520(02)00017-X
   Forman JP, 2013, HYPERTENSION, V61, P779, DOI 10.1161/HYPERTENSIONAHA.111.00659
   Forrest KYZ, 2011, NUTR RES, V31, P48, DOI 10.1016/j.nutres.2010.12.001
   Gallagher JC, 2013, J CLIN ENDOCR METAB, V98, P1137, DOI 10.1210/jc.2012-3106
   Gibney KB, 2008, CLIN INFECT DIS, V46, P443, DOI 10.1086/525268
   Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604
   Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560
   Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174
   GRAHAM NMH, 1992, JAMA-J AM MED ASSOC, V267, P369, DOI 10.1001/jama.267.3.369
   HIND CRK, 1990, THORAX, V45, P957, DOI 10.1136/thx.45.12.957
   Holick MF, 2006, J CLIN INVEST, V116, P2062, DOI 10.1172/JCI29449
   Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385
   Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218
   Kahn LS, 2011, J NATL MED ASSOC, V103, P407, DOI 10.1016/S0027-9684(15)30337-0
   Kaysen GA, 2001, KIDNEY INT, V60, P333, DOI 10.1046/j.1523-1755.2001.00804.x
   Klein RS, 2005, CLIN INFECT DIS, V41, P1794, DOI 10.1086/498311
   Laaksi I, 2007, AM J CLIN NUTR, V86, P714
   Lange CM, 2011, J HEPATOL, V54, P887, DOI 10.1016/j.jhep.2010.08.036
   Lappe JM, 2007, AM J CLIN NUTR, V85, P1586
   Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182
   McComsey GA, 2007, AIDS, V21, P2473, DOI 10.1097/QAD.0b013e3282ef961d
   MCLAUGHLIN M, 1974, LANCET, V1, P536
   Meier C, 2004, J BONE MINER RES, V19, P1221, DOI 10.1359/JBMR.040511
   MELLER Y, 1986, ISRAEL J MED SCI, V22, P8
   Moore CE, 2005, J NUTR, V135, P2478
   Ormesher B, 2011, AIDS, V25, P1237, DOI 10.1097/QAD.0b013e3283474ef9
   Petta S, 2010, HEPATOLOGY, V51, P1158, DOI 10.1002/hep.23489
   Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009
   Powe CE, 2011, J BONE MINER RES, V26, P1609, DOI 10.1002/jbmr.387
   Rao J, 2009, J CLIN GASTROENTEROL, V43, P94, DOI 10.1097/MCG.0b013e3180cabc14
   REICHMAN LB, 1979, ARCH INTERN MED, V139, P337, DOI 10.1001/archinte.139.3.337
   Rodriguez M, 2009, AIDS RES HUM RETROV, V25, P9, DOI 10.1089/aid.2008.0183
   STAMP TCB, 1974, NATURE, V247, P563, DOI 10.1038/247563a0
   StataCorp, 2012, STAT STAT SOFTW REL
   Tangpricha V, 2002, AM J MED, V112, P659, DOI 10.1016/S0002-9343(02)01091-4
   VANDERSCHUEREN D, 1991, CALCIFIED TISSUE INT, V49, P84, DOI 10.1007/BF02565126
   Visser M, 2003, J CLIN ENDOCR METAB, V88, P5766, DOI 10.1210/jc.2003-030604
   Vlahov D, 1991, NIDA Res Monogr, V109, P75
   von Hurst PR, 2010, BRIT J NUTR, V103, P549, DOI 10.1017/S0007114509992017
   Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127
   Wasserman P, 2010, AIDS PATIENT CARE ST, V24, P223, DOI 10.1089/apc.2009.0241
   WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373
   Witham MD, 2009, J HYPERTENS, V27, P1948, DOI 10.1097/HJH.0b013e32832f075b
   YETLEY EA, 2008, AM J CLIN NUTR, V88, P558
   Zadshir Ashraf, 2005, Ethn Dis, V15, pS5
   Zhu K, 2010, J AM GERIATR SOC, V58, P2063, DOI 10.1111/j.1532-5415.2010.03142.x
NR 68
TC 10
Z9 10
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 22
PY 2014
VL 9
IS 4
AR e95802
DI 10.1371/journal.pone.0095802
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AG2IS
UT WOS:000335240300096
PM 24756000
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Zheng, YY
   Zhu, JH
   Zhou, MR
   Cui, L
   Yao, WM
   Liu, YY
AF Zheng, Yayuan
   Zhu, Jianhong
   Zhou, Manru
   Cui, Liao
   Yao, Weimin
   Liu, Yuyu
TI Meta-Analysis of Long-Term Vitamin D Supplementation on Overall
   Mortality
SO PLOS ONE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; EARLY
   POSTMENOPAUSAL WOMEN; HIGH-DOSE CHOLECALCIFEROL; NURSING-HOME RESIDENTS;
   CHRONIC KIDNEY-DISEASE; BONE-MINERAL DENSITY; DOUBLE-BLIND;
   ELDERLY-WOMEN; OLDER-PEOPLE
AB Introduction: It has been suggested that vitamin D is effective to prevent mortality. However, there is no consistent conclusion that the effects of vitamin D supplementation on all-cause mortality are associated with duration of treatment. We conducted a meta-analysis regarding this issue in an effort to provide a more robust answer.
   Methods: A comprehensive search in a number of databases, including MEDLINE, Embase and The Cochrane Central Register of Controlled Trials, was conducted for collecting randomized controlled trials (RCTs) on vitamin D supplementation preventing mortality. Two investigators independently screened the literature according to the inclusive and exclusive criteria and the relative data were extracted. Data analysis was performed by using Review Manager 5.0 software.
   Results: Data from forty-two RCT s were included. Vitamin D therapy significantly decreased all-cause mortality with a duration of follow-up longer than 3 years with a RR (95% CI) of 0.94 (0.90-0.98). No benefit was seen in a shorter follow-up periods with a RR (95% CI) of 1.04 (0.97-1.12). Results remain robust after sensitivity analysis. The following subgroups of long-term follow-up had significantly fewer deaths: female only, participants with a mean age younger than 80, daily dose of 800 IU or less, participants with vitamin D insufficiency (baseline 25-hydroxyvitamin D level less than 50 nmol/L) and cholecalciferol therapy. In addition, the combination of vitamin D and calcium significantly reduced mortality and vitamin D alone also had a trend to decrease mortality in a longer time follow up.
   Conclusions: The data suggest that supplementation of vitamin D is effective in preventing overall mortality in a long-term treatment, whereas it is not significantly effective in a treatment duration shorter than 3 years. Future studies are needed to identify the efficacy of vitamin D on specific mortality, such as cancer and cardiovascular disease mortality in a long-term treatment duration.
C1 [Zheng, Yayuan; Zhu, Jianhong; Zhou, Manru; Cui, Liao; Liu, Yuyu] Guangdong Med Coll, Dept Pharmacol, Zhanjiang, Peoples R China.
   [Yao, Weimin] Guangdong Med Coll, Inst Resp Dis, Zhanjiang, Peoples R China.
RP Yao, WM (reprint author), Guangdong Med Coll, Inst Resp Dis, Zhanjiang, Peoples R China.
EM 616286464@qq.com; liuyuyu77@yeah.net
FU National Natural Science Foundation of China [81102450]
FX This study was funded by the grants from National Natural Science
   Foundation of China (81102450). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abbas S, 2009, INT J CANCER, V124, P250, DOI 10.1002/ijc.23904
   Aloia JF, 2005, ARCH INTERN MED, V165, P1618, DOI 10.1001/archinte.165.14.1618
   Alvarez JA, 2012, AM J CLIN NUTR, V96, P672, DOI 10.3945/ajcn.112.040642
   Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027
   Artaza JN, 2009, CLIN J AM SOC NEPHRO, V4, P1515, DOI 10.2215/CJN.02260409
   Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730
   Avenell Alison, 2004, Clin Trials, V1, P490, DOI 10.1191/1740774504cn053oa
   Avenell A, 2012, J CLIN ENDOCR METAB, V97, P614, DOI 10.1210/jc.2011-1309
   Baeksgaard L, 1998, OSTEOPOROSIS INT, V8, P255, DOI 10.1007/s001980050062
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Bischoff-Ferrari HA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3692
   Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617
   BJELAKOVIC G, 2011, COCHRANE DB SYST REV, V7
   Bjoerkman M, 2008, AGE AGEING, V37, P25, DOI 10.1093/ageing/afm141
   Bolland MJ, 2011, AM J CLIN NUTR, V94, P1144, DOI 10.3945/ajcn.111.015032
   Bolton-Smith C, 2007, J BONE MINER RES, V22, P509, DOI 10.1359/JBMR.070116
   Bouillon R, 2006, J STEROID BIOCHEM, V102, P156, DOI 10.1016/j.jsbmb.2006.09.014
   Brazier M, 2005, CLIN THER, V27, P1885, DOI 10.1016/j.clinthera.2005.12.010
   Broe KE, 2007, J AM GERIATR SOC, V55, P234, DOI 10.1111/j.1532-5415.2007.01048.x
   Burleigh E, 2007, AGE AGEING, V36, P507, DOI 10.1093/ageing/afm087
   Cashman KD, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.5383
   Chapuy MC, 2002, OSTEOPOROSIS INT, V13, P257, DOI 10.1007/s001980200023
   CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305
   Chel V, 2008, OSTEOPOROSIS INT, V19, P663, DOI 10.1007/s00198-007-0465-2
   Chen PZ, 2010, BREAST CANCER RES TR, V121, P469, DOI 10.1007/s10549-009-0593-9
   Chung Mei, 2009, Evid Rep Technol Assess (Full Rep), P1
   Cooper L, 2003, AM J CLIN NUTR, V77, P1324
   DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Flicker L, 2005, J AM GERIATR SOC, V53, P1881, DOI 10.1111/j.1532-5415.2005.00468.x
   Gepner AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036617
   Gilbert R, 2011, CANCER CAUSE CONTROL, V22, P319, DOI 10.1007/s10552-010-9706-3
   Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174
   Harwood RH, 2004, AGE AGEING, V33, P45, DOI 10.1093/ageing/afh002
   HIGGINS JPT, 2008, COCHRANE HDB SYSTEMA
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Holick MF, 2004, AM J CLIN NUTR, V79, P362
   Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491
   Kalyani RR, 2010, J AM GERIATR SOC, V58, P1299, DOI 10.1111/j.1532-5415.2010.02949.x
   Kilkkinen A, 2008, CANCER EPIDEM BIOMAR, V17, P3274, DOI 10.1158/1055-9965.EPI-08-0199
   Komulainen M, 1999, J CLIN ENDOCR METAB, V84, P546, DOI 10.1210/jc.84.2.546
   Krieg MA, 1999, OSTEOPOROSIS INT, V9, P483, DOI 10.1007/s001980050174
   Lappe JM, 2007, AM J CLIN NUTR, V85, P1586
   Larsen ER, 2004, J BONE MINER RES, V19, P370, DOI 10.1359/JBMR.0301240
   Latham NK, 2003, J AM GERIATR SOC, V51, P291, DOI 10.1046/j.1532-5415.2003.51101.x
   Lavie CJ, 2011, J AM COLL CARDIOL, V58, P1547, DOI 10.1016/j.jacc.2011.07.008
   Law M, 2006, AGE AGEING, V35, P482, DOI 10.1093/ageing/afj080
   Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050
   Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004
   Lips P, 1996, ANN INTERN MED, V124, P400, DOI 10.7326/0003-4819-124-4-199602150-00003
   Lips P, 2010, AM J CLIN NUTR, V91, P985, DOI 10.3945/ajcn.2009.28113
   Lyons RA, 2007, OSTEOPOROSIS INT, V18, P811, DOI 10.1007/s00198-006-0309-5
   Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566
   Margolis KL, 2008, HYPERTENSION, V52, P847, DOI 10.1161/HYPERTENSIONAHA.108.114991
   Mathieu C, 2005, DIABETOLOGIA, V48, P1247, DOI 10.1007/s00125-005-1802-7
   Meier C, 2004, J BONE MINER RES, V19, P1221, DOI 10.1359/JBMR.040511
   Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629
   Meyer HE, 2002, J BONE MINER RES, V17, P709, DOI 10.1359/jbmr.2002.17.4.709
   Michaelsson K, 2010, AM J CLIN NUTR, V92, P841, DOI 10.3945/ajcn.2010.29749
   Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6
   OOMS ME, 1995, J CLIN ENDOCR METAB, V80, P1052, DOI 10.1210/jc.80.4.1052
   Porthouse J, 2005, BMJ-BRIT MED J, V330, P1003, DOI 10.1136/bmj.330.7498.1003
   Prince RL, 2008, ARCH INTERN MED, V168, P103, DOI 10.1001/archinternmed.2007.31
   Punthakee Z, 2012, DIABETOLOGIA, V55, P36, DOI 10.1007/s00125-011-2357-4
   Ravani P, 2009, KIDNEY INT, V75, P88, DOI 10.1038/ki.2008.501
   Rejnmark L, 2012, J CLIN ENDOCR METAB, V97, P2670, DOI 10.1210/jc.2011-3328
   Rovner AJ, 2008, PEDIATRICS, V122, P907, DOI 10.1542/peds.2008-1743
   Salovaara K, 2010, J BONE MINER RES, V25, P1487, DOI 10.1002/jbmr.48
   Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594
   Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754
   Sugden JA, 2008, DIABETIC MED, V25, P320, DOI 10.1111/j.1464-5491.2007.02360.x
   Thacher TD, 2011, MAYO CLIN PROC, V86, P50, DOI 10.4065/mcp.2010.0567
   Touvier M, 2011, CANCER EPIDEM BIOMAR, V20, P1003, DOI 10.1158/1055-9965.EPI-10-1141
   Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469
   Uusi-Rasi K, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.21082
   van den Bergh Joop P W, 2011, Curr Osteoporos Rep, V9, P36, DOI 10.1007/s11914-010-0041-0
   Wahl D A, 2012, Arch Osteoporos, V7, P155, DOI 10.1007/s11657-012-0093-0
   Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127
   Wasse H, 2012, AM J CLIN NUTR, V95, P522, DOI 10.3945/ajcn.111.025502
   Wejse C, 2009, AM J RESP CRIT CARE, V179, P843, DOI 10.1164/rccm.200804-567OC
   Witham MD, 2010, CIRC-HEART FAIL, V3, P195, DOI 10.1161/CIRCHEARTFAILURE.109.907899
   Zhu K, 2008, J CLIN ENDOCR METAB, V93, P743, DOI 10.1210/jc.2007-1466
NR 82
TC 44
Z9 49
U1 0
U2 22
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 3
PY 2013
VL 8
IS 12
AR UNSP e82109
DI 10.1371/journal.pone.0082109
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 265JR
UT WOS:000327947800084
PM 24349197
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Gandini, S
   De Vries, E
   Tosti, G
   Botteri, E
   Spadola, G
   Maisonneuve, P
   Martinoli, C
   Joosse, A
   Ferrucci, PF
   Baldini, F
   Cocorocchio, E
   Pennacchioli, E
   Cataldo, F
   Bazolli, B
   Clerici, A
   Barberis, M
   Bataille, V
   Testori, A
AF Gandini, Sara
   De Vries, Esther
   Tosti, Giulio
   Botteri, Edoardo
   Spadola, Giuseppe
   Maisonneuve, Patrick
   Martinoli, Chiara
   Joosse, Arjen
   Ferrucci, Pier Francesco
   Baldini, Federica
   Cocorocchio, Emilia
   Pennacchioli, Elisabetta
   Cataldo, Francesco
   Bazolli, Barbara
   Clerici, Alessandra
   Barberis, Massimo
   Bataille, Veronique
   Testori, Alessandro
TI Sunny Holidays before and after Melanoma Diagnosis Are Respectively
   Associated with Lower Breslow Thickness and Lower Relapse Rates in Italy
SO PLOS ONE
LA English
DT Article
ID CUTANEOUS MALIGNANT-MELANOMA; RANDOMIZED CONTROLLED-TRIALS; VITAMIN-D
   SUPPLEMENTATION; RISK-FACTORS; RECALL BIAS; EXPOSURE; MORTALITY; CANCER;
   METAANALYSIS; SURVIVAL
AB Background: Previous studies have reported an association between sun exposure and improved cutaneous melanoma (CM) survival. We analysed the association of UV exposure with prognostic factors and outcome in a large melanoma cohort.
   Methods: A questionnaire was given to 289 (42%) CM patients at diagnosis (Group 1) and to 402 CM patients (58%) during follow-up (Group 2). Analyses were carried out to investigate the associations between sun exposure and melanoma prognostic factors and survival.
   Results: Holidays in the sun two years before CM diagnosis were significantly associated with lower Breslow thickness (p=0.003), after multiple adjustment. Number of weeks of sunny holidays was also significantly and inversely associated with thickness in a dose-dependent manner (p=0.007). However when stratifying by gender this association was found only among women (p=0.0004) the risk of CM recurrence in both sexes was significantly lower in patients (n=271) who had holidays in the sun after diagnosis, after multiple adjustment including education: HR=0.30 (95% CI: 0.10-0.87; p=0.03) conclusions: Holidays in the sun were associated with thinner melanomas in women and reduced rates of relapse in both sexes. However, these results do not prove a direct causal effect of sun exposure on survival since other confounding factors, such as vitamin D serum levels and socio-economic status, may play a role. Other factors in sun seeking individuals may also possibly affect these results.
C1 [Gandini, Sara; Botteri, Edoardo; Maisonneuve, Patrick; Bazolli, Barbara; Clerici, Alessandra] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy.
   [De Vries, Esther; Joosse, Arjen] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands.
   [Tosti, Giulio; Spadola, Giuseppe; Baldini, Federica; Pennacchioli, Elisabetta; Cataldo, Francesco; Testori, Alessandro] European Inst Oncol, Div Melanoma & Muscle Cutaneous Sarcomas, Milan, Italy.
   [Martinoli, Chiara; Ferrucci, Pier Francesco; Cocorocchio, Emilia] European Inst Oncol, Dept Med Oncol, Milan, Italy.
   [Barberis, Massimo] European Inst Oncol, Dept Pathol & Lab Med, Milan, Italy.
   [Bataille, Veronique] Kings Coll London, Twin Res & Genet Epidemiol Unit, London WC2R 2LS, England.
RP Gandini, S (reprint author), European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy.
EM sara.gandini@ieo.it
RI de Vries, Esther/A-6603-2009; gandini, sara/J-4916-2018; maisonneuve,
   patrick/U-9789-2018
OI de Vries, Esther/0000-0002-5560-2258; gandini, sara/0000-0002-1348-4548;
   maisonneuve, patrick/0000-0002-5309-4704; ferrucci, pier
   francesco/0000-0001-6255-5851; martinoli, chiara/0000-0002-8173-5046
FU Fondazione Grazia Focacci
FX The authors thank the "Fondazione Grazia Focacci" for the financial
   support. The funder had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730
   Berwick M, 2005, J NATL CANCER I, V97, P195, DOI 10.1093/jnci/dji019
   Beswick S, 2009, J CLIN ONCOL, V27, P5439
   Carnevale V, 2001, OSTEOPOROSIS INT, V12, P1026, DOI 10.1007/s001980170012
   Cockburn M, 2001, AM J EPIDEMIOL, V153, P1021, DOI 10.1093/aje/153.10.1021
   Davies JR, 2011, CANCER CAUSE CONTROL, V22, P1471, DOI 10.1007/s10552-011-9827-3
   de Vries E, 2003, INT J CANCER, V107, P119, DOI 10.1002/ijc.11360
   Egan KM, 2005, JNCI-J NATL CANCER I, V97, P161, DOI 10.1093/jnci/dji047
   Gambichler T, 2013, BRIT J DERMATOL, V168, P625, DOI 10.1111/j.1365-2133.2012.11212.x
   Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016
   Gandini S, 2011, INT J CANCER, V128, P1414, DOI 10.1002/ijc.25439
   Gandini S, 2009, EUR J CANCER, V45, P634, DOI 10.1016/j.ejca.2008.10.003
   Granelli F., 2012, ARCH DERMATOL, P1
   Guerrieri-Gonzaga A, 2013, PIGM CELL MELANOMA R, V26, P16, DOI 10.1111/pcmr.12036
   HOLMAN CDJ, 1986, J NATL CANCER I, V76, P403
   Idorn LW, 2013, BRIT J DERMATOL, V168, P367, DOI 10.1111/bjd.12066
   Idorn LW, 2011, BRIT J DERMATOL, V165, P164, DOI 10.1111/j.1365-2133.2011.10348.x
   Lazzeroni M, 2013, ANTI-CANCER AGENT ME, V13, P118, DOI 10.2174/187152013804487281
   Mandala M, 2011, MAYO CLIN PROC, V86, P113, DOI 10.4065/mcp.2010.0671
   Newton Bishop J, 2006, MELANOMA RES, V16
   Parr CL, 2009, AM J EPIDEMIOL, V169, P257, DOI 10.1093/aje/kwn363
   Raimondi S, 2009, CARCINOGENESIS, V30, P1170, DOI 10.1093/carcin/bgp103
   Randerson-Moor JA, 2009, EUR J CANCER, V45, P3271, DOI 10.1016/j.ejca.2009.06.011
   Rosso S, 2008, EUR J CANCER, V44, P1275, DOI 10.1016/j.ejca.2008.03.009
   Soto E, 2010, MELANOMA RES, V20, P147, DOI 10.1097/CMR.0b013e328328f802
   Tryggvadottir L, 2010, ACTA ONCOL, V49, P665, DOI 10.3109/02841861003702528
   Yang L, 2011, CANCER EPIDEM BIOMAR, V20, P683, DOI 10.1158/1055-9965.EPI-10-0982
NR 27
TC 9
Z9 9
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 4
PY 2013
VL 8
IS 11
AR e78820
DI 10.1371/journal.pone.0078820
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 245ZC
UT WOS:000326503400089
PM 24223851
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Sperati, F
   Vici, P
   Maugeri-Sacca, M
   Stranges, S
   Santesso, N
   Mariani, L
   Giordano, A
   Sergi, D
   Pizzuti, L
   Di Lauro, L
   Montella, M
   Crispo, A
   Mottolese, M
   Barba, M
AF Sperati, Francesca
   Vici, Patrizia
   Maugeri-Sacca, Marcello
   Stranges, Saverio
   Santesso, Nancy
   Mariani, Luciano
   Giordano, Antonio
   Sergi, Domenico
   Pizzuti, Laura
   Di Lauro, Luigi
   Montella, Maurizio
   Crispo, Anna
   Mottolese, Marcella
   Barba, Maddalena
TI Vitamin D Supplementation and Breast Cancer Prevention: A Systematic
   Review and Meta-Analysis of Randomized Clinical Trials
SO PLOS ONE
LA English
DT Review
ID SERUM 25-HYDROXYVITAMIN D; INDEPENDENT PROSTATE-CANCER; DIETARY
   MODIFICATION TRIAL; PLACEBO-CONTROLLED TRIAL; BONE-MINERAL DENSITY;
   COLORECTAL-CANCER; POSTMENOPAUSAL WOMEN; CALCIUM SUPPLEMENTATION;
   CARDIOVASCULAR-DISEASE; ANTIOXIDANT VITAMINS
AB In recent years, the scientific evidence linking vitamin D status or supplementation to breast cancer has grown notably. To investigate the role of vitamin D supplementation on breast cancer incidence, we conducted a systematic review and meta-analysis of randomized controlled trials comparing vitamin D with placebo or no treatment. We used OVID to search MEDLINE (R), EMBASE and CENTRAL until April 2012. We screened the reference lists of included studies and used the "Related Article'' feature in PubMed to identify additional articles. No language restrictions were applied. Two reviewers independently extracted data on methodological quality, participants, intervention, comparison and outcomes. Risk Ratios and 95% Confident Intervals for breast cancer were pooled using a random-effects model. Heterogeneity was assessed using the I-2 test. In sensitivity analysis, we assessed the impact of vitamin D dosage and mode of administration on treatment effects. Only two randomized controlled trials fulfilled the pre-set inclusion criteria. The pooled analysis included 5372 postmenopausal women. Overall, Risk Ratios and 95% Confident Intervals were 1.11 and 0.74-1.68. We found no evidence of heterogeneity. Neither vitamin D dosage nor mode of administration significantly affected breast cancer risk. However, treatment efficacy was somewhat greater when vitamin D was administered at the highest dosage and in combination with calcium (Risk Ratio 0.58, 95% Confident Interval 0.23-1.47 and Risk Ratio 0.93, 95% Confident Interval 0.54-1.60, respectively). In conclusions, vitamin D use seems not to be associated with a reduced risk of breast cancer development in postmenopausal women. However, the available evidence is still limited and inadequate to draw firm conclusions. Study protocol code: FARM8L2B5L.
C1 [Sperati, Francesca] Regina Elena Inst Canc Res, Bostat Sci Direct, Rome, Italy.
   [Vici, Patrizia; Sergi, Domenico; Pizzuti, Laura; Di Lauro, Luigi] Regina Elena Inst Canc Res, Div Med Oncol B, Rome, Italy.
   [Maugeri-Sacca, Marcello; Barba, Maddalena] Regina Elena Inst Canc Res, Div Med Oncol B, Sci Direct, Rome, Italy.
   [Stranges, Saverio] Warwick Med Sch, Coventry, W Midlands, England.
   [Santesso, Nancy] McMaster Univ, Hlth Sci Ctr, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4L8, Canada.
   [Mariani, Luciano] Regina Elena Inst Canc Res, Div Gynecol Oncol, Rome, Italy.
   [Giordano, Antonio] Temple Univ, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA.
   [Giordano, Antonio] Temple Univ, Ctr Biotechnol, Philadelphia, PA 19122 USA.
   [Montella, Maurizio; Crispo, Anna] Natl Canc Inst, G Pascale Fdn, Epidemiol Unit, Naples, Italy.
   [Mottolese, Marcella] Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy.
RP Barba, M (reprint author), Regina Elena Inst Canc Res, Div Med Oncol B, Sci Direct, Rome, Italy.
EM maddalena.barba@gmail.com
RI Sergi, Domenico/K-5832-2016; Maugeri, Marcello/K-2350-2014; Giordano,
   Antonio/F-1927-2010; Sperati, Francesca/K-5843-2016; Barba,
   Maddalena/K-7277-2018
OI Sergi, Domenico/0000-0002-8639-5378; Maugeri,
   Marcello/0000-0003-2287-9581; Giordano, Antonio/0000-0002-5959-016X;
   Sperati, Francesca/0000-0002-6038-2798; Barba,
   Maddalena/0000-0001-9050-2917; Crispo, Anna/0000-0002-8455-3328
FU Italian Medicines Agency (AIFA) [FARM8L2B5L]
FX This project was supported by grant code FARM8L2B5L from the Italian
   Medicines Agency (AIFA). The content is solely the responsibility of the
   authors and does not necessarily represent the official views of the
   financing institution. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Amir E, 2012, BREAST CANCER RES TR, V133, P1077, DOI 10.1007/s10549-012-2012-x
   Attia S, 2008, CLIN CANCER RES, V14, P2437, DOI 10.1158/1078-0432.CCR-07-4274
   Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730
   Avenell A, 2012, J CLIN ENDOCR METAB, V97, P614, DOI 10.1210/jc.2011-1309
   Beer TM, 2005, CLIN CANCER RES, V11, P7794, DOI 10.1158/1078-0432.CCR-05-0552
   Beer TM, 2004, AM J CLIN ONCOL-CANC, V27, P535, DOI 10.1097/01.coc.0000136020.27904.9c
   Beer TM, 2008, CANCER, V112, P2377, DOI 10.1002/cncr.23461
   Beer TM, 2007, CANCER CHEMOTH PHARM, V59, P581, DOI 10.1007/s00280-006-0299-1
   Beresford SAA, 2006, JAMA-J AM MED ASSOC, V295, P643, DOI 10.1001/jama.295.6.643
   Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18
   Bjelakovic G, 2008, COCHRANE DATABASE SY, V4
   Boscoe FP, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-264
   Chlebowski RT, 2008, J NATL CANCER I, V100, P1581, DOI 10.1093/jnci/djn360
   Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005
   Ding EL, 2008, INT J CANCER, V122, P1690, DOI 10.1002/ijc.23311
   Dizdar O, 2007, BREAST, V17, P120
   Egger M, 2001, SYSTEMATIC REV HLTH
   Eliassen AH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2880
   Ellis GK, 2008, J CLIN ONCOL, V26, P4875, DOI 10.1200/JCO.2008.16.3832
   Fakih MG, 2007, CLIN CANCER RES, V13, P1216, DOI 10.1158/1078-0432.CCR-06-1165
   Fedirko V, 2009, CANCER PREV RES, V2, P212
   Fedirko V, 2012, CANCER CAUSE CONTROL, V23, P1149, DOI 10.1007/s10552-012-9984-z
   Femiano F, 2001, INT J ORAL MAX SURG, V30, P402, DOI 10.1054/ijom.2001.0107
   Finkelstein JS, 2006, NEW ENGL J MED, V354, P750, DOI 10.1056/NEJMe068007
   Forman MR, 2006, NEW ENGL J MED, V354, P752, DOI 10.1056/NEJMe068006
   Freedman DM, 2010, CANCER RES, V70, P8587, DOI 10.1158/0008-5472.CAN-10-1420
   Freedman DM, 1999, CANCER EPIDEM BIOMAR, V8, P1115
   Frost P, 2009, J NATL MED ASSOC, V101, P1310, DOI 10.1016/S0027-9684(15)31151-2
   Galan P, 2003, REV EPIDEMIOL SANTE, V51, P147
   Garland CF, 2007, NUTR REV, V65, pS91, DOI 10.1111/j.1753-4887.2007.tb00349.x
   GARLAND FC, 1990, PREV MED, V19, P614, DOI 10.1016/0091-7435(90)90058-R
   Garssen J, 1998, J PHOTOCH PHOTOBIO B, V42, P167, DOI 10.1016/S1011-1344(97)00122-X
   Giovannucci E, 2005, CANCER CAUSE CONTROL, V16, P83, DOI 10.1007/s10552-004-1661-4
   Glen H, 2006, EXPERT REV ANTICANC, V6, P305, DOI 10.1586/14737140.6.3.305
   Glinghammar B, 1997, AM J CLIN NUTR, V66, P1277
   Goodwin PJ, 2009, J CLIN ONCOL, V27, P2117, DOI 10.1200/JCO.2008.20.8629
   GORHAM ED, 1990, INT J EPIDEMIOL, V19, P820, DOI 10.1093/ije/19.4.820
   Grant WB, 2003, RECENT RESULTS CANC, V164, P371
   Grant WB, 2002, CANCER, V94, P272, DOI 10.1002/cncr.10196
   Grant WB, 2009, INT J EPIDEMIOL, V37, P1209
   Grant WB, 2008, AM J PATHOL, V173, P1589, DOI 10.2353/ajpath.2008.080579
   Grau MV, 2003, J NATL CANCER I, V95, P1765, DOI 10.1093/jnci/djg110
   GROBER U, 2009, DTSCH APOTH-ZTG, V149, P62
   Gross C, 1998, J UROLOGY, V159, P2035, DOI 10.1016/S0022-5347(01)63236-1
   Hager ED, 2006, DTSCH Z ONKOLOGIE, V38, P32
   Harstrick A, 2000, ONKOLOGE, V6, P443
   Hartman AL, 2002, CLIN PEDIATR, V41, P731, DOI 10.1177/000992280204100916
   Hartman J J, 2000, Orthop Nurs, V19, P63, DOI 10.1097/00006416-200019010-00013
   Hartman TJ, 2005, J NUTR, V135, P252
   Harvey JA, 2009, MENOPAUSE, V16, P1193, DOI [10.1097/gme.0b013e3181a7fb1e, 10.1097/gme.0b013e3181a7fb1c]
   Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440
   HELLSTROM E, 1990, EUR J HAEMATOL, V45, P255
   Henriksen DB, 2009, BONE, V45, P833, DOI 10.1016/j.bone.2009.07.008
   Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335
   Hercberg S, 1999, FOOD CHEM TOXICOL, V37, P925, DOI 10.1016/S0278-6915(99)00078-2
   Hercberg S, 2007, J NUTR, V137, P2098
   Hercberg S, 2006, BRIT J NUTR, V96, pS28, DOI 10.1079/BJN20061695
   Higgins JPT, 2011, COCHRANE HDB SYSTEMA
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Hines SL, 2010, NUTRITION, V26, P255, DOI 10.1016/j.nut.2009.08.020
   Hines SL, 2009, BREAST CANCER RES TR, V117, P603, DOI 10.1007/s10549-009-0332-2
   Hines SL, 2009, J CLIN ONCOL, V27, P1047, DOI 10.1200/JCO.2008.19.1783
   Holick MF, 2006, NEW ENGL J MED, V354, P2287
   Holick MF, 2004, AM J CLIN NUTR, V79, P362
   Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385
   Hollis BW, 2004, AM J CLIN NUTR, V80, p1752S, DOI 10.1093/ajcn/80.6.1752S
   Holt PR, 2002, CANCER EPIDEM BIOMAR, V11, P113
   Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655
   Inanir A, 2004, J INT MED RES, V32, P570, DOI 10.1177/147323000403200602
   Ingraham BA, 2008, CURR MED RES OPIN, V24, P139, DOI 10.1185/030079907X253519
   Jacobs ET, 2009, CANCER PREV RES, V2, P197, DOI 10.1158/1940-6207.CAPR-09-0019
   Jacobs TP, 2005, J CLIN ENDOCR METAB, V90, P6316, DOI 10.1210/jc.2005-0675
   Ji Y, 2002, CELL CYCLE, V1, P410, DOI 10.4161/cc.1.6.269
   Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005
   Kerst A, 2007, GENEESMIDDELENBULLET, V41, P133
   Kuhn T, 2013, INT J CANCER, DOI [10.1002/ijc.28172.2013, DOI 10.1002/IJC.28172.2013]
   Kulbersh JS, 2009, OTOLARYNG HEAD NECK, V140, P235, DOI 10.1016/j.otohns.2008.11.011
   LaCroix AZ, 2009, J GERONTOL A-BIOL, V64, P559, DOI 10.1093/gerona/glp006
   Lappe JM, 2007, AM J CLIN NUTR, V85, P1586
   Lehmann B, 2004, EXP DERMATOL, V13, P11, DOI 10.1111/j.1600-0625.2004.00257.x
   Lin J, 2007, ARCH INTERN MED, V167, P1050, DOI 10.1001/archinte.167.10.1050
   Lips P, 2001, J CLIN ENDOCR METAB, V86, P1212, DOI 10.1210/jc.86.3.1212
   Manson JE, 2012, CONTEMP CLIN TRIALS, V33, P159, DOI 10.1016/j.cct.2011.09.009
   Markopoulos C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2565
   Millen AE, 2010, AM J CLIN NUTR, V91, P1324, DOI 10.3945/ajcn.2009.28908
   Mohr SB, 2011, ANTICANCER RES, V31, P2939
   Neuhouser ML, 2001, NUTR CANCER, V39, P12, DOI 10.1207/S15327914nc391_2
   Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8
   Perez EA, 2006, J CLIN ONCOL, V24, P3629, DOI 10.1200/JCO.2005.05.4882
   Prentice RL, 2008, ANNU REV PUBL HEALTH, V29, P131, DOI [10.1146/annurev.publhealth.29.020907.090947, 10.1146/anntirev.publhealth.29.020907.090947]
   Price Nancy, 2004, Clin Prostate Cancer, V2, P202
   Pritchard RS, 1996, CANCER EPIDEM BIOMAR, V5, P897
   Qiao SJ, 2003, J STEROID BIOCHEM, V85, P1, DOI 10.1016/S0960-0760(03)00142-0
   Raimondi S, 2009, CARCINOGENESIS, V30, P1170, DOI 10.1093/carcin/bgp103
   Recker RR, 1999, ANN INTERN MED, V130, P897, DOI 10.7326/0003-4819-130-11-199906010-00005
   Rejnmark L, 2012, J CLIN ENDOCR METAB, V97, P2670, DOI 10.1210/jc.2011-3328
   Roh JL, 2009, CANCER, V115, P251, DOI 10.1002/cncr.24027
   Rohan TE, 2008, CANCER PREV RES, V1, P275, DOI 10.1158/1940-6207.CAPR-08-0003
   Ryan CW, 2007, UROLOGY, V70, P122, DOI 10.1016/j.urology.2007.03.026
   Schilsky RL, 2010, ONCOLOGIST, V15, P484, DOI 10.1634/theoncologist.2010-0079
   Schumann SA, 2007, J FAM PRACTICE, V56, P907
   Schwartz GG, 2007, CURR OPIN CLIN NUTR, V10, P6
   Schwartz GG, 2006, J NATL CANCER I, V98, P428, DOI 10.1093/jnci/djj127
   Sidelnikov E, 2010, CANCER EPIDEM BIOMAR, V19, P1022, DOI 10.1158/1055-9965.EPI-09-0526
   Sieg J, 2006, ANTICANCER RES, V26, P2729
   Skinner HG, 2008, CANCER BIOL THER, V7, P437, DOI 10.4161/cbt.7.3.5585
   Spina CS, 2006, ANTICANCER RES, V26, P2515
   STERN PH, 1991, MOL PHARMACOL, V39, P557
   Sutton A.J., 2000, METHODS METAANALYSIS
   Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469
   Van Veldhuizen PJ, 2000, J UROLOGY, V163, P187, DOI 10.1016/S0022-5347(05)68001-9
   VANDERWIELEN RPJ, 1995, LANCET, V346, P207, DOI 10.1016/S0140-6736(95)91266-5
   Verner AM, 2007, COCHRANE DATABASE SY, V4
   Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222
   Williamson CS, 2006, NUTR BULL, V31, P77, DOI 10.1111/j.1467-3010.2006.00558.x
   Witham MD, 2010, CIRC-HEART FAIL, V3, P195, DOI 10.1161/CIRCHEARTFAILURE.109.907899
   Wong SSL, 2006, J MED LIBR ASSOC, V94, P451
   Woo TCS, 2005, NUTR CANCER, V51, P32, DOI 10.1207/s15327914nc5101_5
   Wood HM, 2000, PROSTATE J, V2, P6
   Yin L, 2010, EUR J CANCER, V46, P2196, DOI 10.1016/j.ejca.2010.03.037
   YOSHIDA Y, 1993, INT J CLIN PHARM RES, V13, P21
   Zhou FL, 2008, J EXPT HEMATOLOGY, V13, P8961
   Zhou W, 2005, CANCER EPIDEM BIOMAR, V14, P2303, DOI 10.1158/1055-9965.EPI-05-0335
   Zittermann A, 2005, BRIT J NUTR, V94, P483, DOI 10.1079/BJN20051544
NR 124
TC 29
Z9 29
U1 0
U2 44
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 22
PY 2013
VL 8
IS 7
AR e69269
DI 10.1371/journal.pone.0069269
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 187PW
UT WOS:000322132100051
PM 23894438
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Skaaby, T
   Husemoen, LLN
   Pisinger, C
   Jorgensen, T
   Thuesen, BH
   Fenger, M
   Linneberg, A
AF Skaaby, Tea
   Husemoen, Lise Lotte Nystrup
   Pisinger, Charlotta
   Jorgensen, Torben
   Thuesen, Betina Heinsbaek
   Fenger, Mogens
   Linneberg, Allan
TI Vitamin D Status and Cause-Specific Mortality: A General Population
   Study
SO PLOS ONE
LA English
DT Article
ID SERUM 25-HYDROXYVITAMIN D; CARDIOVASCULAR-DISEASE MORTALITY; NUTRITION
   EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; ALL-CAUSE MORTALITY;
   BREAST-CANCER RISK; LIVER-DISEASE; D DEFICIENCY; D SUPPLEMENTATION; D
   LEVEL
AB Background: Vitamin D deficiency is associated with an increased risk of all-cause mortality in observational studies. The specific causes of death underlying this association lack clarity. We investigated the association between vitamin D status and cause-specific mortality.
   Methods: We included a total of 9,146 individuals from the two population-based studies, Monica10 and Inter99, conducted in 1993-94 and 1999-2001, respectively. Vitamin D status was assessed as serum 25-hydroxyvitamin D. Information on causes of death was obtained from The Danish Register of Causes of Death until 31 December 2009. There were a total of 832 deaths (median follow-up 10.3 years).
   Results: Multivariable Cox regression analyses with age as underlying time axis and vitamin D quartiles showed significant associations between vitamin D status and death caused by diseases of the respiratory system, the digestive system, and endocrine, nutritional and metabolic diseases with hazard ratios (HRs) 0.26 (p(trend) = 0.0042), 0.28 (p(trend) = 0.0040), and 0.21 (p(trend) = 0.035), respectively, for the fourth vitamin D quartile compared to the first. We found non-significantly lower HRs for death caused by mental and behavioural diseases and diseases of the nervous system, but no association between vitamin D status and death caused by neoplasms or diseases of the circulatory system.
   Conclusion: The associations of vitamin D status and cause-specific mortality suggest that we also look elsewhere (than to cardiovascular disease and cancer) to explain the inverse association between vitamin D status and mortality.
C1 [Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Pisinger, Charlotta; Jorgensen, Torben; Thuesen, Betina Heinsbaek; Linneberg, Allan] Glostrup Cty Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark.
   [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark.
   [Jorgensen, Torben] Aalborg Univ, Fac Med, Aalborg, Denmark.
   [Fenger, Mogens] Univ Copenhagen, Hvidovre Hosp, Dept Clin Biochem, DK-2650 Hvidovre, Denmark.
RP Skaaby, T (reprint author), Glostrup Cty Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark.
EM tea.skaaby.01@regionh.dk
RI Jorgensen, Torben/Z-1335-2018
OI Skaaby, Tea/0000-0003-0031-5726; Jorgensen, Torben/0000-0001-9453-2830;
   Thuesen, Betina/0000-0001-9772-4344; Linneberg,
   Allan/0000-0002-0994-0184
FU Health Insurance Foundation [2010 B 131]; Lundbeck Foundation
   [R108-2012-10225]
FX The present study was supported by The Health Insurance Foundation
   (grant number 2010 B 131). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abbas S, 2009, INT J CANCER, V124, P250, DOI 10.1002/ijc.23904
   Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716
   Alvarez JA, 2010, INT J ENDOCRINOL, DOI 10.1155/2010/351385
   Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027
   Annweiler C, 2011, NEUROEPIDEMIOLOGY, V37, P249, DOI 10.1159/000334177
   Arteh J, 2010, DIGEST DIS SCI, V55, P2624, DOI 10.1007/s10620-009-1069-9
   Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730
   Barchetta I, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-85
   Bikle DD, 2007, J BONE MINER RES, V22, pV50, DOI 10.1359/JBMR.07S208
   Black PN, 2005, CHEST, V128, P3792, DOI 10.1378/chest.128.6.3792
   Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004
   Carter GD, 2004, CLIN CHEM, V50, P2195, DOI 10.1373/clinchem.2004.040683
   Dobak John, 1994, Journal of Dermatological Science, V8, P18, DOI 10.1016/0923-1811(94)90316-6
   Forouhi NG, 2008, DIABETES, V57, P2619, DOI 10.2337/db08-0593
   Freedman DM, 2010, CANCER RES, V70, P8587, DOI 10.1158/0008-5472.CAN-10-1420
   Ginde AA, 2009, J AM GERIATR SOC, V57, P1595, DOI 10.1111/j.1532-5415.2009.02359.x
   Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560
   Grant WB, 2011, DERM-ENDOCRINOL, V3, P199, DOI 10.4161/derm.3.3.15364
   Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y
   Hogberg G, 2012, ACTA PAEDIAT
   Holick MF, 2005, J NUTR, V135, p2739S
   Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553
   Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491
   Hutchinson MS, 2010, EUR J ENDOCRINOL, V162, P935, DOI 10.1530/EJE-09-1041
   Hypponen E, 2006, DIABETES CARE, V29, P2244, DOI 10.2337/dc06-0946
   [IARC WHO], 2008, VIT D CANC
   Jakobsen J, 2009, SCAND J CLIN LAB INV, V69, P190, DOI 10.1080/00365510802471570
   Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005
   Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377
   Juel K, 1999, DAN MED BULL, V46, P354
   Kilkkinen A, 2008, CANCER EPIDEM BIOMAR, V17, P3274, DOI 10.1158/1055-9965.EPI-08-0199
   Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115
   Llewellyn DJ, 2010, ARCH INTERN MED, V170, P1135, DOI 10.1001/archinternmed.2010.173
   Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566
   Malham M, 2011, WORLD J GASTROENTERO, V17, P922, DOI 10.3748/wjg.v17.i7.922
   Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629
   Olsen MH, 2007, EUR HEART J, V28, P1374, DOI 10.1093/eurheartj/ehl448
   Pappa HM, 2008, CURR OPIN GASTROEN, V24, P176, DOI 10.1097/MOG.0b013e3282f4d2f3
   Petta S, 2010, HEPATOLOGY, V51, P1158, DOI 10.1002/hep.23489
   Pilz S, 2009, CLIN ENDOCRINOL, V71, P666, DOI 10.1111/j.1365-2265.2009.03548.x
   Pittas AG, 2010, DIABETES CARE, V33, P2021, DOI 10.2337/dc10-0790
   Putz-Bankuti C, 2012, LIVER INT, V32, P845, DOI 10.1111/j.1478-3231.2011.02735.x
   Rejnmark L, 2012, J CLIN ENDOCR METAB, V97, P2670, DOI 10.1210/jc.2011-3328
   Rolland Y, 2012, J GERONTOL A
   Romme EA, 2012, ANN MED
   Semba RD, 2010, EUR J CLIN NUTR, V64, P203, DOI 10.1038/ejcn.2009.140
   The World Health Organisation (WHO), 2000, WHO TECH REP SER, V894, pi
   Thomas GN, 2012, DIABETES CARE, V35, P1158, DOI 10.2337/dc11-1714
   Thuesen B, 2012, BONE, V50, P605, DOI 10.1016/j.bone.2011.12.016
   Thyssen JP, 2012, J ALLERGY CLIN IMMUN
   Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469
   Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127
   Yin L, 2010, EUR J CANCER, V46, P2196, DOI 10.1016/j.ejca.2010.03.037
NR 53
TC 24
Z9 25
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 20
PY 2012
VL 7
IS 12
AR e52423
DI 10.1371/journal.pone.0052423
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 060RA
UT WOS:000312794500162
PM 23285034
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Kramer, H
   Sempos, C
   Cao, GC
   Luke, A
   Shoham, D
   Cooper, R
   Durazo-Arvizu, R
AF Kramer, Holly
   Sempos, Chris
   Cao, Guichan
   Luke, Amy
   Shoham, David
   Cooper, Richard
   Durazo-Arvizu, Ramon
TI Mortality Rates Across 25-Hydroxyvitamin D (25[OH] D) Levels among
   Adults with and without Estimated Glomerular Filtration Rate < 60
   ml/min/1.73 m(2) : The Third National Health and Nutrition Examination
   Survey
SO PLOS ONE
LA English
DT Article
ID CHRONIC KIDNEY-DISEASE; VITAMIN-D DEFICIENCY; SERUM PARATHYROID-HORMONE;
   CARDIOVASCULAR-DISEASE; HYPOVITAMINOSIS-D; D SUPPLEMENTATION; D
   INSUFFICIENCY; US POPULATION; UNITED-STATES; OLDER MEN
AB Background: Previous studies exploring the association between 25[OH]D levels and mortality in adults with and without kidney disease utilized 25[OH]D thresholds that have recently been scrutinized by the Institute of Medicine Committee to Review Dietary References Intakes for Vitamin D and Calcium.
   Objective: We explored all-cause mortality rates across the spectrum of 25[OH]D levels over an eighteen-year follow-up among adults with and without an estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m(2).
   Design: The study included 1,097 U.S. adults with eGFR <60 ml/min/1.73 m(2) and 14, 002 adults with eGFR >= 60 ml/min/1.73 m2. Mortality rates and rate ratios (RR) across 25[OH]D groups were calculated with Poisson regression and restricted cubic splines while adjusting for covariates.
   Results: Prevalence of 25[OH]D levels <30 and <20 ng/ml among adults with eGFR <60 ml/min/1.73 m(2) was 76.5% (population estimate 6.2 million) and 35.4% (population estimate 2.9 million), respectively. Among adults with eGFR >= 60 ml/min/1.73 m(2), 70.5% had 25[OH] D levels <30 ng/ml (population estimate 132.2 million) while 30.3% had 25[OH]D levels <20 ng/ml (population estimate 56.8 million). Significantly higher mortality rates were noted among individuals with 25[OH]D levels <12 ng/ml compared to referent group (24 to <30 ng/ml): RR1.41 (95% CI 1.17, 1.71) among individuals with eGFR <60 ml/min/1.73 m(2) and RR 1.32 (95% CI 1.13, 1.56) among individuals with eGFR >= 60 ml/min/1.73 m(2) after adjustment for covariates including co-morbid conditions. Mortality rates were fairly similar across all 25[OH]D groups with levels >20 ng/ml after adjustment for all covariates.
   Conclusions: Regardless of presence of eGFR <60 ml/min/1.73 m(2), mortality rates across groups with 25[OH] D levels 2040 ng/ml are similar.
C1 [Kramer, Holly; Cao, Guichan; Luke, Amy; Shoham, David; Cooper, Richard; Durazo-Arvizu, Ramon] Loyola Univ, Med Ctr, Dept Prevent Med & Epidemiol, Maywood, IL 60153 USA.
   [Kramer, Holly] Loyola Univ, Med Ctr, Dept Med, Maywood, IL 60153 USA.
   [Kramer, Holly] Loyola Univ, Med Ctr, Div Nephrol & Hypertens, Maywood, IL 60153 USA.
   [Sempos, Chris] NIH, Off Dietary Supplements, Bethesda, MD 20892 USA.
RP Kramer, H (reprint author), Loyola Univ, Med Ctr, Dept Prevent Med & Epidemiol, 2160 S 1st Ave, Maywood, IL 60153 USA.
EM hkramer@lumc.edu
OI Kramer, Holly/0000-0002-6374-837X
FU National Institutes of Health [1R01DK90360-1A1]
FX This study was funded by a grant from the National Institutes of Health
   (1R01DK90360-1A1). The funders had no role in study design, data
   collection and analysis, decision to publish or preparation of the
   manuscript.
CR Adami S, 2008, BONE, V42, P267, DOI 10.1016/j.bone.2007.10.003
   Aloia JF, 2006, AM J CLIN NUTR, V84, P602
   [Anonymous], 2010, NHANES 3 LINKED MORT
   [Anonymous], 2010, SURVEY OPERATIONS MA
   [Anonymous], 1996, NATL CTR HLTH STAT S
   [Anonymous], 1992, INT STAT CLASSIFICAT
   Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730
   Cawthon PM, 2010, J CLIN ENDOCR METAB, V95, P4625, DOI 10.1210/jc.2010-0638
   Chapuy MC, 1997, OSTEOPOROSIS INT, V7, P439, DOI 10.1007/s001980050030
   Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007
   Emmanuele E, 2012, ATHEROSCLEROSIS, V223, P280
   Greenberg ER, 2005, ANN INTERN MED, V142, P75, DOI 10.7326/0003-4819-142-1-200501040-00112
   Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4
   Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553
   Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385
   Hollis BW, 2008, CURR OPIN ENDOCRINOL, V15, P489, DOI 10.1097/MED.0b013e328317ca6c
   Institute of Medicine, 2011, DIETARY REFERENCE IN
   Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218
   LaClair RE, 2005, AM J KIDNEY DIS, V45, P1026, DOI 10.1053/j.ajkd.2005.02.029
   Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006
   Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009
   Malabanan A, 1998, LANCET, V351, P805, DOI 10.1016/S0140-6736(05)78933-9
   Mehrotra R, 2008, CLIN J AM SOC NEPHRO, V3, P1144, DOI 10.2215/CJN.05781207
   Mehrotra R, 2009, KIDNEY INT, V76, P977, DOI 10.1038/ki.2009.288
   Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629
   Melamed ML, 2009, J AM SOC NEPHROL, V20, P2631, DOI 10.1681/ASN.2009030283
   Michaelsson K, 2010, AM J CLIN NUTR, V92, P841, DOI 10.3945/ajcn.2010.29749
   Michos ED, 2009, FUTUR CARDIOL, V5, P15, DOI 10.2217/14796678.5.1.15
   Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110
   Norman AW, 2008, AM J CLIN NUTR, V88, P1455, DOI 10.3945/ajcn.2008.27049
   Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802
   Pilz S, 2008, STROKE, V39, P2611, DOI 10.1161/STROKEAHA.107.513655
   Pilz S, 2009, NAT REV CARDIOL, V6, P621, DOI 10.1038/nrcardio.2009.135
   Ravani P, 2009, KIDNEY INT, V75, P88, DOI 10.1038/ki.2008.501
   Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020
   Stolzenberg-Solomon RZ, 2010, AM J EPIDEMIOL, V172, P81, DOI 10.1093/aje/kwq120
   Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375
   Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127
   Wolf M, 2007, KIDNEY INT, V72, P1004, DOI 10.1038/sj.ki.5002451
   Zittermann A, 2012, AM J CLIN NUTR, V95, P91, DOI 10.3945/ajcn.111.014779
   1991, INT CLASSIFICATION D
NR 41
TC 13
Z9 13
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 24
PY 2012
VL 7
IS 10
AR e47458
DI 10.1371/journal.pone.0047458
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 026VC
UT WOS:000310310200041
PM 23112816
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Gepner, AD
   Ramamurthy, R
   Krueger, DC
   Korcarz, CE
   Binkley, N
   Stein, JH
AF Gepner, Adam D.
   Ramamurthy, Rekha
   Krueger, Diane C.
   Korcarz, Claudia E.
   Binkley, Neil
   Stein, James H.
TI A Prospective Randomized Controlled Trial of the Effects of Vitamin D
   Supplementation on Cardiovascular Disease Risk
SO PLOS ONE
LA English
DT Article
ID NUTRITION EXAMINATION SURVEY; C-REACTIVE PROTEIN; ARTERIAL STIFFNESS; D
   DEFICIENCY; ENDOTHELIAL FUNCTION; 25-HYDROXYVITAMIN D;
   MYOCARDIAL-INFARCTION; NATIONAL-HEALTH; CLINICAL-TRIAL; BLOOD-PRESSURE
AB Vitamin D (VitD) supplementation has been advocated for cardiovascular risk reduction; however, supporting data are sparse. The objective of this study was to determine whether VitD supplementation reduces cardiovascular risk. Subjects in this prospective, randomized, double-blind, placebo-controlled trial of post-menopausal women with serum 25-hydroxyvitamin D concentrations > 10 and <60 ng/mL were randomized to Vitamin D3 2500 IU or placebo, daily for 4 months. Primary endpoints were changes in brachial artery flow-mediated vasodilation (FMD), carotid-femoral pulse wave velocity (PWV), and aortic augmentation index (AIx). The 114 subjects were mean (standard deviation) 63.9 (3.0) years old with a 25-hydroxyvitamin D level of 31.3 (10.6) ng/mL. Low VitD (<30 ng/mL) was present in 47% and was associated with higher body-mass index, systolic blood pressure, glucose, CRP, and lower FMD (all p<0.05). After 4 months, 25-hydroxyvitamin D levels increased by 15.7 (9.3) ng/mL on vitamin D3 vs. -0.2 (6.1) ng/mL on placebo (p<0.001). There were no significant differences between groups in changes in FMD (0.3 [3.4] vs. 0.3 [2.6] %, p = 0.77), PWV (0.00 [1.06] vs. 0.05 [0.92] m/s, p = 0.65), AIx (2.7 [6.3] vs. 0.9 [5.6] %, p = 0.10), or CRP (0.3 [1.9] vs. 0.3 [4.2] mg/L, p = 0.97). Multivariable models showed no significant interactions between treatment group and low VitD status (, 30 ng/mL) for changes in FMD (p = 0.65), PWV (p = 0.93), AIx (p = 0.97), or CRP (p = 0.26). In conclusion, VitD supplementation did not improve endothelial function, arterial stiffness, or inflammation. These observations do not support use of VitD supplementation to reduce cardiovascular disease risk.
C1 [Gepner, Adam D.; Ramamurthy, Rekha; Krueger, Diane C.; Korcarz, Claudia E.; Binkley, Neil; Stein, James H.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA.
RP Gepner, AD (reprint author), Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA.
EM jhs@medicine.wisc.edu
RI ; Korcarz, Claudia/A-5728-2018
OI Stein, James/0000-0002-2770-8223; Korcarz, Claudia/0000-0001-9691-9027
FU University of Wisconsin School of Medicine and Public Health Institute
   of Clinical and Translational Research; University of Wisconsin
FX This work has no commercial sponsor but was supported by the University
   of Wisconsin School of Medicine and Public Health Institute of Clinical
   and Translational Research and the University of Wisconsin Osteoporosis
   Clinical Center and Research Program. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Amer M, 2012, AM J CARDIOL, V109, P226, DOI 10.1016/j.amjcard.2011.08.032
   Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027
   Andrade J, 2008, CLIN J AM SOC NEPHRO, V3, P1800, DOI 10.2215/CJN.00900208
   Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730
   Binkley N, 2006, CLIN CHEM, V52, P2124, DOI 10.1373/clinchem.2006.074922
   Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974
   Cannell J, 2008, EXPERT OPIN PHARMACO, V9, P107, DOI 10.1517/14656566.9.1.107
   Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6
   Dong YB, 2010, J CLIN ENDOCR METAB, V95, P4584, DOI 10.1210/jc.2010-0606
   Geleijnse JM, 2010, AM J HYPERTENS, V24, P253
   Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174
   Heaney RP, 2003, AM J CLIN NUTR, V77, P204
   Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553
   Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491
   INOUE M, 1992, LIFE SCI, V51, P1105, DOI 10.1016/0024-3205(92)90511-M
   Jablonski KL, 2011, HYPERTENSION, V57, P63, DOI 10.1161/HYPERTENSIONAHA.110.160929
   Johnson HM, 2010, J AM COLL CARDIOL, V55, P1988, DOI 10.1016/j.jacc.2010.03.002
   Korcarz CE, 2010, SLEEP, V33, P1081, DOI 10.1093/sleep/33.8.1081
   Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254
   Lavie CJ, 2011, J AM COLL CARDIOL, V58, P1547, DOI 10.1016/j.jacc.2011.07.008
   Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050
   Lensmeyer GL, 2006, CLIN CHEM, V52, P1120, DOI 10.1373/clinchem.2005.064956
   Li YC, 2002, J CLIN INVEST, V110, P229, DOI 10.1172/JCI200215219
   LIND L, 1995, AM J HYPERTENS, V8, P894, DOI 10.1016/0895-7061(95)00154-H
   Looker AC, 2002, BONE, V30, P771, DOI 10.1016/S8756-3282(02)00692-0
   Margolis KL, 2008, HYPERTENSION, V52, P847, DOI 10.1161/HYPERTENSIONAHA.108.114991
   Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159
   Mheid I. A., 2011, J AM COLL CARDIOL, V58, P186
   O'Keefe JH, 2011, JAMA-J AM MED ASSOC, V306, P1546, DOI 10.1001/jama.2011.1465
   OConnell TD, 1997, AM J PHYSIOL-HEART C, V272, pH1751
   Oliver JJ, 2003, ARTERIOSCL THROM VAS, V23, P554, DOI 10.1161/01.ATV.0000060460.52916.D6
   Poole KES, 2006, STROKE, V37, P243, DOI 10.1161/01.STR.0000195184.24297.c1
   Reddy V.S., 2010, AM J CARDIOL, V106, P798
   Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704
   Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754
   SCRAGG R, 1990, INT J EPIDEMIOL, V19, P559, DOI 10.1093/ije/19.3.559
   Sepulveda JL, 2005, CURR OPIN CARDIOL, V20, P407
   Shapses SA, 2011, JAMA-J AM MED ASSOC, V305, P2565, DOI 10.1001/jama.2011.881
   Sugden JA, 2008, DIABETIC MED, V25, P320, DOI 10.1111/j.1464-5491.2007.02360.x
   Torriani FJ, 2008, J AM COLL CARDIOL, V52, P569, DOI 10.1016/j.jacc.2008.04.049
   Vieth R, 2006, J NUTR, V136, P1117
   Vieth R, 2007, J BONE MINER RES, V22, pV64, DOI 10.1359/JBMR.07S221
   Vita JA, 2002, CIRCULATION, V106, P640, DOI 10.1161/01.CIR.0000028581.07992.56
   Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127
   Witham MD, 2010, DIABETOLOGIA, V53, P2112, DOI 10.1007/s00125-010-1838-1
   Witham MD, 2010, CIRC-HEART FAIL, V3, P195, DOI 10.1161/CIRCHEARTFAILURE.109.907899
NR 46
TC 109
Z9 109
U1 2
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 7
PY 2012
VL 7
IS 5
AR e36617
DI 10.1371/journal.pone.0036617
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959TC
UT WOS:000305335000044
PM 22586483
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

EF